<SEC-DOCUMENT>0001615219-22-000131.txt : 20220815
<SEC-HEADER>0001615219-22-000131.hdr.sgml : 20220815
<ACCEPTANCE-DATETIME>20220812181609
ACCESSION NUMBER:		0001615219-22-000131
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20220808
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220815
DATE AS OF CHANGE:		20220812

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Salarius Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001615219
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				465087339
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36812
		FILM NUMBER:		221161594

	BUSINESS ADDRESS:	
		STREET 1:		2450 HOLCOMBE BLVD
		STREET 2:		SUITE J-608
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77021
		BUSINESS PHONE:		346-772-0346

	MAIL ADDRESS:	
		STREET 1:		2450 HOLCOMBE BLVD
		STREET 2:		SUITE J-608
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77021

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Flex Pharma, Inc.
		DATE OF NAME CHANGE:	20140730
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>flks-20220808.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:ea6c3006-d082-4be1-86a9-12deaf7eab56,g:badc731f-d81c-4203-a19d-45c00d606e24,d:14f76f064d2d445eb4a42c97366bfe11--><html xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>flks-20220808</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV80L2ZyYWc6NzMwZWIwNTA2YTNmNDVlOGI1ODJhYjYxMGRmN2E1OWEvdGFibGU6N2E2NmI4ZDg5NjhiNDY1ZTg2ZDY4ZDI1NTM3MjQwNjgvdGFibGVyYW5nZTo3YTY2YjhkODk2OGI0NjVlODZkNjhkMjU1MzcyNDA2OF8xLTEtMS0xLTI1MTky_669a91eb-756e-42b3-800b-2e018306ff7c">0001615219</ix:nonNumeric><ix:nonNumeric contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV80L2ZyYWc6NzMwZWIwNTA2YTNmNDVlOGI1ODJhYjYxMGRmN2E1OWEvdGFibGU6N2E2NmI4ZDg5NjhiNDY1ZTg2ZDY4ZDI1NTM3MjQwNjgvdGFibGVyYW5nZTo3YTY2YjhkODk2OGI0NjVlODZkNjhkMjU1MzcyNDA2OF8yLTEtMS0xLTI1MTky_ea91f864-7681-47b5-a843-8c4b736b1c15">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="flks-20220808.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001615219</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-12</xbrli:startDate><xbrli:endDate>2022-05-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i14f76f064d2d445eb4a42c97366bfe11_1"></div><div style="min-height:72pt;width:100%"><div style="-sec-extract:summary;margin-bottom:10pt"><img src="flks-20220808_g1.jpg" alt="flks-20220808_g1.jpg" style="height:41px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"/><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.527%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="-sec-extract:summary;margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:133%">SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%">Washington, D.C.&#160; 20549</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGV4dHJlZ2lvbjo1ZTEwMzVkODM1YTY0MGFlYTY5NTQ1NzdmNDNkZmE5MF8xOTcy_66483bb2-afb2-437b-9bf7-2b5777f04628">8-K</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT<br/>Pursuant to Section 13 or 15(d) of the<br/>Securities Exchange Act of 1934</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGV4dHJlZ2lvbjo1ZTEwMzVkODM1YTY0MGFlYTY5NTQ1NzdmNDNkZmE5MF8yMDk_569f8823-c9b8-4f14-8e98-86b4e639457b">August 8, 2022</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGV4dHJlZ2lvbjo1ZTEwMzVkODM1YTY0MGFlYTY5NTQ1NzdmNDNkZmE5MF8xOTcz_928eb024-187f-44f1-8550-760b68dfea8c">SALARIUS PHARMACEUTICALS, INC.</ix:nonNumeric> <br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.762%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.313%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MGI5MzA3MDk0MzI1NGIxOThmMzY3Mzc4MjM4ZTZlNDgvdGFibGVyYW5nZTowYjkzMDcwOTQzMjU0YjE5OGYzNjczNzgyMzhlNmU0OF8wLTAtMS0xLTI1MTky_235e398d-8b0e-49c9-907d-cdcb79e1ab70">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MGI5MzA3MDk0MzI1NGIxOThmMzY3Mzc4MjM4ZTZlNDgvdGFibGVyYW5nZTowYjkzMDcwOTQzMjU0YjE5OGYzNjczNzgyMzhlNmU0OF8wLTItMS0xLTI1MTky_b49d4f9e-d9b8-4223-b126-f04ad999a906">001-36812</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MGI5MzA3MDk0MzI1NGIxOThmMzY3Mzc4MjM4ZTZlNDgvdGFibGVyYW5nZTowYjkzMDcwOTQzMjU0YjE5OGYzNjczNzgyMzhlNmU0OF8wLTYtMS0xLTI1MTky_53f9939c-904c-408b-810b-7f64dfa792eb">46-5087339</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(State or other jurisdiction of incorporation)</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(IRS Employer Identification Number)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.05pt;margin-top:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MGI5MzA3MDk0MzI1NGIxOThmMzY3Mzc4MjM4ZTZlNDgvdGFibGVyYW5nZTowYjkzMDcwOTQzMjU0YjE5OGYzNjczNzgyMzhlNmU0OF8zLTAtMS0xLTI1MTkyL3RleHRyZWdpb246ZWRmMmQ2ZjgzYzIwNDkxYjgyOTJmYmNlNTUzNzJhODVfNQ_ffbbfa1b-93b0-4f0f-bde5-5a006982e977">2450 Holcombe Blvd.</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MGI5MzA3MDk0MzI1NGIxOThmMzY3Mzc4MjM4ZTZlNDgvdGFibGVyYW5nZTowYjkzMDcwOTQzMjU0YjE5OGYzNjczNzgyMzhlNmU0OF8zLTAtMS0xLTI1MTkyL3RleHRyZWdpb246ZWRmMmQ2ZjgzYzIwNDkxYjgyOTJmYmNlNTUzNzJhODVfOA_6775fa33-9fb1-496d-9a97-fb90c45103d8">Suite X</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MGI5MzA3MDk0MzI1NGIxOThmMzY3Mzc4MjM4ZTZlNDgvdGFibGVyYW5nZTowYjkzMDcwOTQzMjU0YjE5OGYzNjczNzgyMzhlNmU0OF8zLTAtMS0xLTI1MTkyL3RleHRyZWdpb246ZWRmMmQ2ZjgzYzIwNDkxYjgyOTJmYmNlNTUzNzJhODVfMTE_a951fac7-d8c5-4b76-8530-d101a9b8a04e">Houston</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MGI5MzA3MDk0MzI1NGIxOThmMzY3Mzc4MjM4ZTZlNDgvdGFibGVyYW5nZTowYjkzMDcwOTQzMjU0YjE5OGYzNjczNzgyMzhlNmU0OF8zLTAtMS0xLTI1MTkyL3RleHRyZWdpb246ZWRmMmQ2ZjgzYzIwNDkxYjgyOTJmYmNlNTUzNzJhODVfMTU_98594f81-9cec-4496-aac2-cec1e3827534">TX</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MGI5MzA3MDk0MzI1NGIxOThmMzY3Mzc4MjM4ZTZlNDgvdGFibGVyYW5nZTowYjkzMDcwOTQzMjU0YjE5OGYzNjczNzgyMzhlNmU0OF8zLTQtMS0xLTI1MTky_b6a138d2-2229-4e61-ba2b-0cbf7b93ac25">77021</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Zip Code)</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGV4dHJlZ2lvbjo1ZTEwMzVkODM1YTY0MGFlYTY5NTQ1NzdmNDNkZmE5MF8xOTY5_98e186af-471b-4c4f-816d-a08f9b7affc9">832</ix:nonNumeric>) <ix:nonNumeric contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGV4dHJlZ2lvbjo1ZTEwMzVkODM1YTY0MGFlYTY5NTQ1NzdmNDNkZmE5MF8xOTcw_c3953f23-68ac-4dbf-83fc-064a2e615cb9">834-6992</ix:nonNumeric><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A <br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MjdlOGYxMTNlMDQ4NDRjY2EyYzZlYTYzYmE3MTc3MjgvdGFibGVyYW5nZToyN2U4ZjExM2UwNDg0NGNjYTJjNmVhNjNiYTcxNzcyOF8wLTAtMS0xLTI1MTky_449f0097-7c36-4290-9a25-96778ca12b9f">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MjdlOGYxMTNlMDQ4NDRjY2EyYzZlYTYzYmE3MTc3MjgvdGFibGVyYW5nZToyN2U4ZjExM2UwNDg0NGNjYTJjNmVhNjNiYTcxNzcyOF8xLTAtMS0xLTI1MTky_28596e96-c74c-4ac6-a938-4f4973fa9138">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MjdlOGYxMTNlMDQ4NDRjY2EyYzZlYTYzYmE3MTc3MjgvdGFibGVyYW5nZToyN2U4ZjExM2UwNDg0NGNjYTJjNmVhNjNiYTcxNzcyOF8yLTAtMS0xLTI1MTky_b6e079ca-dfa6-4203-a637-942361305338">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MjdlOGYxMTNlMDQ4NDRjY2EyYzZlYTYzYmE3MTc3MjgvdGFibGVyYW5nZToyN2U4ZjExM2UwNDg0NGNjYTJjNmVhNjNiYTcxNzcyOF8zLTAtMS0xLTI1MTky_4a0b05bf-ed32-43d1-af93-6d2c83eee00b">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Securities registered pursuant to Section 12(b) of the Act:</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Title of each class</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Trading Symbol(s)</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Name of each exchange on which registered</span></div><div style="text-align:center"><span><br/></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6NzQ0YTdjNzJmZjIzNGFhNGIwOWI1NmRkYThjZGFiNjcvdGFibGVyYW5nZTo3NDRhN2M3MmZmMjM0YWE0YjA5YjU2ZGRhOGNkYWI2N18xLTAtMS0xLTI1MTky_d0bfdbaf-944b-4825-961f-d5ea4a7ad23f">Common Stock, par value $0.0001</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6NzQ0YTdjNzJmZjIzNGFhNGIwOWI1NmRkYThjZGFiNjcvdGFibGVyYW5nZTo3NDRhN2M3MmZmMjM0YWE0YjA5YjU2ZGRhOGNkYWI2N18xLTItMS0xLTI1MTky_359f5017-1794-4723-81d8-5569c86f8691">SLRX</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Nasdaq Capital Market</span></div></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8201;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8201;240.12b-2 of this chapter).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Emerging growth company </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGV4dHJlZ2lvbjo1ZTEwMzVkODM1YTY0MGFlYTY5NTQ1NzdmNDNkZmE5MF8xOTcx_1593f3f0-16ac-4301-ad85-1a78ee6ca158">&#9744;</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#9744;</span></div><div style="height:78.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:10pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 2.02 Results of Operations and Financial Condition </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 8, 2022, Salarius Pharmaceuticals, Inc. (the &#8220;Company&#8221;) reported financial results for the three months ended June 30, 2022 and other recent corporate updates. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The information in this Item 2.02 of this Current Report on 8-K (including Exhibit 99.1 hereto) is furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information shall not be deemed incorporated by reference into any other filing with the Securities and Exchange Commission made by the Company, whether made before or after today&#8217;s date, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific references in such filing.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Exhibits</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.722%"><tr><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.125%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.705%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Exhibit No.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Description</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">99.1</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="a080822slrx2q22financialre.htm">Press Release Announcing Financial Results, dated August 8, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">104</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cover Page Interactive Data File (embedded within the inline XBRL document)</span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:78.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><span><br/></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">          Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SALARIUS PHARMACEUTICALS, INC.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: August 12, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Mark J. Rosenblum</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mark J. Rosenblum</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</span></div></td></tr></table></div><div style="height:78.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><span><br/></span></div></div></div><div id="i14f76f064d2d445eb4a42c97366bfe11_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> </span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a080822slrx2q22financialre.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i6414128ea48e4789a651570bc2c2979e_1"></div><div style="min-height:94.32pt;width:100%"><div><img alt="image_0.jpg" src="image_0.jpg" style="height:78px;margin-bottom:5pt;vertical-align:text-bottom;width:192px"></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Salarius Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Multiple development and data milestones expected from seclidemstat and SP-3164 programs in 2H22</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Conference call and webcast today at 11&#58;00 a.m. ET</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">HOUSTON (August 8, 2022) &#8211; Salarius Pharmaceuticals, Inc. (Nasdaq&#58; SLRX)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, a clinical-stage biopharmaceutical company developing cancer therapies for patients in need of new treatment options, today reported financial results for the three and six months ended June 30, 2022, and provided a business update.  Highlights of the quarter and recent weeks included&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Financial Highlights</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Cash and equivalents were $22.6 million as of June 30, 2022, compared with $29.2 million as of December 31, 2021</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Tightly managed expenses while progressing toward multiple near-term milestones </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Net loss of $4.7 million, or $0.09 per share, compared with net loss of $3.1 million, or $0.07 per share, for the second quarter of 2021</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Seclidemstat (Targeted Protein Inhibitor) Highlights</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Added the Seattle Cancer Care Alliance &#8211; which is comprised of the Fred Hutchinson Cancer Research Center, Seattle Children's Hospital and University of Washington Medical Center &#8211; and Oregon Health &#38; Sciences University as clinical trial sites, bringing the total number of sites supporting the Phase 1&#47;2 sarcoma clinical trial to 15 with 23 locations across the U.S.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Entered into a development collaboration with Volition Rx to advance rapid epigenetic profiling using Volition&#8217;s Nu.Q&#174; technology to support further development of seclidemstat</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Continued patient enrollment in both the Salarius-sponsored seclidemstat sarcoma clinical trial and the M.D. Anderson Cancer Center investigator-initiated hematologic clinical trial</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SP-3164 (Targeted Protein Degrader) Highlights</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Advanced plans for filing an Investigational New Drug (IND) application in 1H23 after completing the pre-Investigational New Drug meeting process with the U.S. Food and Drug Administration (FDA) </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Introduced SP-3164 to potential strategic partners at BIO International Conference</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;The second quarter and recent weeks were extremely productive for Salarius as we advanced both our programs toward multiple near-term milestones. Our Phase 1&#47;2 study with seclidemstat in Ewing&#8217;s and other FET-rearranged sarcomas is progressing and the investigator-initiated clinical trial with seclidemstat in hematologic or blood cancers at M.D. Anderson Cancer Center is also progressing. We continue to expect clinical updates from both these programs in the second half of the year,&#8221; stated David Arthur, CEO of Salarius Pharmaceuticals. &#8220;In addition, our development collaboration with Volition Rx should support further development of seclidemstat by studying potential biomarkers to allow for a noninvasive method of determining target engagement and assessing potential drug activity in patients.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Mr. Arthur continued, &#8220;And, we were thrilled to add SP-3164 &#8211; a type of targeted protein degrader called a molecular glue &#8211; to our development pipeline earlier this year.  We completed the pre-IND meeting process with the FDA and are proceeding with plans to file an IND in the first half of 2023 and begin clinical studies shortly thereafter. Protein degraders have recently received enormous attention based on their exceptional promise to selectively eliminate cancer-promoting proteins and provide the ability to pursue historically undruggable cancer-promoting targets. We believe protein degradation is an exciting area, in part driven by the commercial success of the first-generation molecular glues, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:94.32pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Revlimid and Pomalyst, which together generated more than $16 billion in 2021 global sales.  We look forward to providing pre-clinical data updates later this year.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Second Quarter Financial Results</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net loss for the second quarter of 2022 was $4.7 million, or $0.09 per share, compared with a net loss of $3.1 million, or $0.07 per share, for the second quarter of 2021.  The increase in net loss was due to higher operating expenses, including development spending on SP-3164, our targeted protein degradation technologies purchased in January 2022. There was no grant revenue in the current quarter.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net cash used for operating activities during the second quarter of 2022 was $3.6 million, compared with $3.2 million during the same quarter last year.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Six Month Financial Results</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net loss for the first half of 2022 was $10.8 million, or $0.22 per share, compared with a net loss of $4.9 million, or $0.13 per share, for the first half of 2021. The increase in net loss was primarily due to higher research and development expense, primarily resulting from the $2.0 million acquisition and development costs for the SP-3164 technology, seclidemstat development costs, and higher general and administrative expenses, when compared to the prior year. Additionally, there was no grant revenue in the current year, compared with grant revenue of $1.8 million in the first half of 2021.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net cash used in operating activities for the first half of 2022 was $7.1 million, an increase of $1.2 million from the prior-year period. The increase is primarily due to higher research and development expense.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As of June 30, 2022, Salarius had cash, cash equivalents and restricted cash of $22.6 million, compared with $29.2 million as of December 31, 2021. Current cash and cash equivalents are expected to fund the company&#8217;s planned operations into 2023. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Conference Call</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Salarius will host a conference call and webcast today, beginning at 11&#58;00 a.m. ET to discuss financial results for the second quarter of 2022 and provide a business update. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Participants are encouraged to pre-register for the conference call </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">here</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> to receive a dedicated dial-in number and personal PIN.   </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Alternatively, participants may access the conference call by dialing&#58;&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">866-777-2509 (U.S. toll-free)&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">412-317-5413 (International)&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">An audio webcast will be accessible via the Investors Events and Presentations section of the Company&#8217;s website </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">http&#58;&#47;&#47;investors.salariuspharma.com&#47;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">here</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Following the conclusion of the conference call, a replay will be available until August 15, 2022, and can be accessed by dialing 877-344-7529 (U.S. toll-free), 855-669-9658 (Canada toll-free) or 412-317-0088 (International) with replay access code 2762786. An archive of the webcast will remain available for a period of time.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">About&#160;Salarius Pharmaceuticals</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing cancer therapies for patients in need of new treatment options. Salarius&#8217; product portfolio includes seclidemstat, which is being studied as a potential treatment for pediatric cancers, sarcomas, and other cancers with limited treatment options, and SP-3164, an oral small molecule protein degrader. Seclidemstat is currently in a Phase 1&#47;2 clinical trial for relapsed&#47;refractory Ewing sarcoma and select additional sarcomas that share a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:94.32pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">similar biology to Ewing sarcoma, also referred to as Ewing-related or FET-rearranged sarcomas. Seclidemstat has received Fast Track Designation, Orphan Drug Designation, and Rare Pediatric Disease Designation for Ewing sarcoma from the U.S. Food and Drug Administration. Salarius has received financial support from the National Pediatric Cancer Foundation to advance the Ewing sarcoma clinical program and was also a recipient of a Product Development Award from the Cancer Prevention and Research Institute of Texas (CPRIT). For more information, please visit </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">salariuspharma.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or follow Salarius on Twitter and LinkedIn.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Forward-Looking Statements</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This press release contains &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, included in this press release are forward-looking statements. These forward-looking statements may be identified by terms such as &#8220;believe,&#8221; &#8220;developing,&#8221; &#8220;may,&#8221; &#8220;potential,&#8221; &#8220;progress,&#8221; &#8220;potential,&#8221; and similar terms or expressions or the negative thereof. Examples of such statements include, but are not limited to, statements relating to the following&#58; the value and benefits of the collaboration with Volition Rx&#59; the ability to use biomarkers to advance Salarius&#8217; product candidates&#59; Salarius&#8217; growth strategy&#59; the value of seclidemstat as a treatment for Ewing sarcoma, Ewing-related sarcomas, and other cancers&#59; expanding the scope of Salarius&#8217; research and focus to high unmet need patient populations&#59; milestones of Salarius&#8217; current and future clinical trials, including the timing of data readouts&#59; and Salarius&#8217; expected financial condition, including the anticipated duration of cash runways and timing regarding needs for additional capital. Salarius may not actually achieve the plans, carry out the intentions or meet the expectations or objectives disclosed in the forward-looking statements. You should not place undue reliance on these forward-looking statements. These statements are subject to risks and uncertainties which could cause actual results and performance to differ materially from those discussed in the forward-looking statements. These risks and uncertainties include, but are not limited to, the following&#58; the sufficiency of Salarius&#8217; capital resources&#59; the ability of, and need for, Salarius to raise additional capital to meet Salarius&#8217; business operational needs and to achieve its business objectives and strategy&#59; future clinical trial results and impact of results on Salarius&#59; that the results of studies and clinical trials may not be predictive of future clinical trial results&#59; risks related to the drug development and the regulatory approval process&#59; the competitive landscape and other industry-related risks&#59; and other risks described in Salarius&#8217; filings with the&#8239;Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2021, as revised or supplemented by its Quarterly Reports on Form 10-Q and other documents filed with the SEC. The forward-looking statements contained in this press release speak only as of the date of this press release and are based on management&#8217;s assumptions and estimates as of such date. Salarius disclaims any intent or obligation to update these forward-looking statements to reflect events or circumstances that exist after the date on which they were made.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Contact&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">LHA Investor Relations</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Kim Sutton Golodetz</font></div><div style="text-align:justify"><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">kgolodetz&#64;lhai.com</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">212-838-3777</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Tables to follow)</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:94.32pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SALARIUS PHARMACEUTICALS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CONSOLIDATED BALANCE SHEETS</font></div><div><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">6&#47;30&#47;2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">12&#47;31&#47;2021</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">(Unaudited)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Assets</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Current assets&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cash and cash equivalents</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$&#160;&#160;&#160;&#160;22,647,005</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$&#160;&#160;&#160;&#160;29,214,380</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Prepaid expenses and other current assets</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">368,161</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">949,215</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total current assets</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">23,015,166</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">30,163,595</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Grants receivable from CPRIT</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,610,490</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,610,490</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other assets</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">162,419</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">193,874</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Goodwill</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8,865,909</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8,865,909</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total assets</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$&#160;&#160;&#160;&#160;33,653,984</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$&#160;&#160;&#160;&#160;40,833,868</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Liabilities and stockholders' equity</font></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Current liabilities&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accounts payable</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$&#160;&#160;&#160;&#160;1,874,749</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$&#160;&#160;&#160;&#160;1,543,096</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accrued expenses and other current liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">895,106</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">567,787</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total liabilities</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,769,855</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,110,883</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Commitments and contingencies (Note 5)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Stockholders' equity&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Preferred stock, $0.0001 par value&#59; 10,000,000 shares authorized&#59; 0 issued and outstanding</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Common stock, $0.0001 par value&#59; 100,000,000 shares authorized&#59; 56,116,243 and 45,241,808 shares issued and outstanding at June&#160;30, 2022 and December&#160;31, 2021, respectively</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5,611</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4,524</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Additional paid-in capital</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">73,903,273</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">70,915,653</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accumulated deficit</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(43,024,755)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(32,197,192)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total stockholders' equity</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">30,884,129</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">38,722,985</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total liabilities and stockholders' equity</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$&#160;&#160;&#160;&#160;33,653,984</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$&#160;&#160;&#160;&#160;40,833,868</font></td></tr></table></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:94.32pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:139%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(Unaudited)</font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.480%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.125%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.480%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.480%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.125%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;margin-top:3.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Three Months Ended</font></div><div style="margin-bottom:1.5pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">June 30 </font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;margin-top:3.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Six Months Ended</font></div><div style="margin-bottom:1.5pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">June 30</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">2022</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">2021</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">2022</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">2021</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Revenue&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Grant revenue</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$&#160;&#160;&#160;&#160;&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$&#160;&#160;&#160;&#160;571,387</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$&#160;&#160;&#160;&#160;&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$&#160;&#160;&#160;&#160;1,840,216</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Research and development</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,921,572</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,096,302</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7,361,047</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3,836,957</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">General and administrative</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,836,395</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,591,905</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3,514,149</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,924,674</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total operating expenses</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4,757,967</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3,688,207</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10,875,196</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">6,761,631</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Loss before other income (expense)</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(4,757,967)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(3,116,820)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(10,875,196)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(4,921,415)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Change in fair value of warrant liability</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">6,427</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">42,186</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">12,235</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(3,868)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Interest income (expense), net</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">33,202</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">265</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">35,398</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(982)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Loss from continuing operations</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">(4,718,338)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">(3,074,369)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">(10,827,563)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">(4,926,265)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Net loss</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">$&#160;&#160;&#160;&#160;(4,718,338)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">$&#160;&#160;&#160;&#160;(3,074,369)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">$&#160;&#160;&#160;&#160;(10,827,563)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">$&#160;&#160;&#160;&#160;(4,926,265)</font></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Loss per common share&#160;&#8212; basic and diluted</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">$&#160;&#160;&#160;&#160;(0.09)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">$&#160;&#160;&#160;&#160;(0.07)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">$&#160;&#160;&#160;&#160;(0.22)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">$&#160;&#160;&#160;&#160;(0.13)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:0.75pt;padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Weighted-average number of common shares outstanding&#160;&#8212; basic and diluted</font></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">53,522,468</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">44,756,201</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">49,908,914</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">37,654,521</font></td></tr></table></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"># # #</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>flks-20220808.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ea6c3006-d082-4be1-86a9-12deaf7eab56,g:badc731f-d81c-4203-a19d-45c00d606e24-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:flks="http://www.flex-pharma.com/20220808" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.flex-pharma.com/20220808">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="flks-20220808_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="flks-20220808_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.flex-pharma.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>flks-20220808_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ea6c3006-d082-4be1-86a9-12deaf7eab56,g:badc731f-d81c-4203-a19d-45c00d606e24-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityAddressAddressLine1_2d6c64f9-b794-452b-9224-250aa4ae5a97_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_2bf1b62b-8d12-4acb-9e6b-08af30d0d01f_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_6c306946-225e-4f67-a2e3-5171796ba871_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_00d285f4-a4cf-48f8-ad94-4e80206144da_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_87de7f0c-b6f5-4042-9726-f799c000c878_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_22bfdfba-2137-427a-9a13-f7403eb9c7d4_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_35531690-9cba-4ee7-869d-e05291108eb0_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_128e3c9e-6757-447a-8545-69cd76e3d4a8_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_5e4ab51f-d2ac-4b05-af78-d28033a27d61_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_b88a8752-3b42-47b4-a813-8dabaf3774d4_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_26c3656b-7c20-48ce-b148-bea8e0362cfc_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_96d0bf2a-6195-4536-9119-ffed80666df6_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_26df7dde-0283-4d00-9a46-577779d318d9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_2742ad21-fe9e-4251-8a7c-15a6dae77ec0_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_d091724b-92ba-4275-92a3-da42f4c7b063_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_e1295246-d02b-4aef-9e16-e15472dcd744_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_a5fa8715-3d08-4791-9416-e8177c7a2dc1_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_a618f1cf-4e4c-45a7-90b0-ffd497f5bda5_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_81fea65d-b9ca-455a-9c74-67a2293bb057_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_2087089b-2e97-4318-a275-4530a3109f49_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_7a97d09b-61e9-45cd-8975-d6202ee97cfc_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_c9d1eb4a-16b6-47af-bd73-0c1a22d8bd7c_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>flks-20220808_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ea6c3006-d082-4be1-86a9-12deaf7eab56,g:badc731f-d81c-4203-a19d-45c00d606e24-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.flex-pharma.com/role/CoverPage" xlink:type="simple" xlink:href="flks-20220808.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.flex-pharma.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_2ffce9ee-3d55-4185-919b-16ef843f91c3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:to="loc_dei_DocumentType_2ffce9ee-3d55-4185-919b-16ef843f91c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_80ab6690-5bb9-493e-ad3a-23efc041a54f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:to="loc_dei_DocumentPeriodEndDate_80ab6690-5bb9-493e-ad3a-23efc041a54f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_6029cb0a-ac00-4902-8346-dcdd0eaa786e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:to="loc_dei_EntityRegistrantName_6029cb0a-ac00-4902-8346-dcdd0eaa786e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_fa5644d5-595a-4a57-9c04-2a244d9f63e6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_fa5644d5-595a-4a57-9c04-2a244d9f63e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_17aef7a7-c49c-480d-ace5-b819a2f6c8d1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:to="loc_dei_EntityFileNumber_17aef7a7-c49c-480d-ace5-b819a2f6c8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_59cf6750-de1e-4a6f-92f1-bcda8bec1686" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:to="loc_dei_EntityTaxIdentificationNumber_59cf6750-de1e-4a6f-92f1-bcda8bec1686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_6c8f852e-68ce-4773-879b-c9c397124e1d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:to="loc_dei_EntityAddressAddressLine2_6c8f852e-68ce-4773-879b-c9c397124e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_2c360eec-511a-4906-8b9e-8d52ec4f9076" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:to="loc_dei_EntityAddressAddressLine1_2c360eec-511a-4906-8b9e-8d52ec4f9076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_b5a77a47-0099-49f1-bac0-5efbef9ffda2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:to="loc_dei_EntityAddressCityOrTown_b5a77a47-0099-49f1-bac0-5efbef9ffda2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_37b84f88-bc2a-48c5-99d9-f0fb5918f590" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:to="loc_dei_EntityAddressStateOrProvince_37b84f88-bc2a-48c5-99d9-f0fb5918f590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_67c9cf71-7302-4f73-a4d0-ecc9720e0277" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:to="loc_dei_EntityAddressPostalZipCode_67c9cf71-7302-4f73-a4d0-ecc9720e0277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_470d219d-fdb3-4209-aa6c-fbdd301df418" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:to="loc_dei_CityAreaCode_470d219d-fdb3-4209-aa6c-fbdd301df418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_5960105b-5fe0-44c3-b6b9-8eae732c0593" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:to="loc_dei_LocalPhoneNumber_5960105b-5fe0-44c3-b6b9-8eae732c0593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_5f8e1c7a-9b3b-4c70-a2f7-7deff5601efa" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:to="loc_dei_WrittenCommunications_5f8e1c7a-9b3b-4c70-a2f7-7deff5601efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_72666651-f11b-4812-85d0-2fdf7eaed546" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:to="loc_dei_SolicitingMaterial_72666651-f11b-4812-85d0-2fdf7eaed546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_10294f7c-e45c-4127-bfe8-9b2a0f1f9ea2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:to="loc_dei_PreCommencementTenderOffer_10294f7c-e45c-4127-bfe8-9b2a0f1f9ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_9bd23f7d-baf7-4871-a069-21f6da17c64e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_9bd23f7d-baf7-4871-a069-21f6da17c64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_d43f8271-05cb-417e-94d8-0be0f87bbcc2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:to="loc_dei_Security12bTitle_d43f8271-05cb-417e-94d8-0be0f87bbcc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_76fbe7c9-d48c-4f75-8d17-3749a716b908" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:to="loc_dei_TradingSymbol_76fbe7c9-d48c-4f75-8d17-3749a716b908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_633ca6c9-eda4-44a4-bcd7-1f1ba4fea8e6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:to="loc_dei_EntityEmergingGrowthCompany_633ca6c9-eda4-44a4-bcd7-1f1ba4fea8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_967db076-d7e0-4d09-8ccb-214d11f9e195" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:to="loc_dei_EntityCentralIndexKey_967db076-d7e0-4d09-8ccb-214d11f9e195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c6c619e1-4544-4452-95a9-3471cd0deec7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f190910f-200e-4bda-8bb1-1df03e1ed07d" xlink:to="loc_dei_AmendmentFlag_c6c619e1-4544-4452-95a9-3471cd0deec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>flks-20220808_g1.jpg
<TEXT>
begin 644 flks-20220808_g1.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #R E@# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=+7RV3Z8RWDST,5_"/DO2-?U'P_]M.G7DED;RU>SN&B;:7A?&],^AP,U] _
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MK4M3GN;6/;M/ELQ()'8GKCWK[0_X)/\ A>\_M/Q]XD:-ET_RK?3XY.SR L[
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M?M]?LO\ B'P5\4-9\=Z-I=QJ/A/793>3S6L9D^Q7#?ZQ9 .55C\P;ISCM7R
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M-&&21",%2#U!%? T\\H0J2J^P;<M[S;_ $/W&GD694*,:%'&1C&*LDJ4=/\
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MYEXB_:.\!^%=<O=(U+5I(+^SD\J:,6TC!6],@8-9O_#5_P -?^@W)_X"2?\
MQ->C'+,;)*4:,FGY,\6>>Y53DX3Q4$UHUS+?[SU^BO-/#/[17@3Q?KUGH^EZ
MK)/?W;%(8S;NH8@$]2,= :]+KEK8>MAI*-:#BWW5CT,+C<-CH.IA:BFEI>+3
MU^045R?A_P"*7ASQ1XIU+P[IU\9]6T_=]HA\MEV;6"GDC!Y(KK*BI2G2?+4B
MT_,UHXBEB(\]&2DKVT=]5N@HK!\:>-M'^'^AMJ^N7)M+!9%B,@0O\S' & *T
M=&U>UU_2;/4K&3S;.[B6:&3!&Y&&0<'VI>SFH*HXOE>E^EP5>DZKH*2YTKVO
MK;O;L7:*X?QU\9_"7PWU*"QU_46L[F>+SHT$+OE<XSD#U%<W_P -5_#7_H.M
M_P" TG_Q-=E/+\95BITZ4FGU29YU;.<MP]1TJV(A&2W3DDU^)ZY17D?_  U7
M\-?^@ZW_ (#2?_$UV'@'XI>'/B9'>R>'KXWJV;*LQ,;)M+ D=1[&IJX#%T(.
MI5I2BEU::16'S?+L545&AB(2D^BDF_N3.LHK*\4>)].\&Z#=ZSJLQM]/M5#2
MR!2VT$@#@<]2*3PMXHT[QEH-KK&DS_:=/N@6BD*E<@$@\'GJ#7+[.?)[7E?+
M>U^E^QW^WI>U]AS+GM>U];;7MVOU-:BBN+\>?&+PC\-R(]=UB*WN2-PM8P9)
MB/78O(_&G2HU*\E"E%R?9:BQ&)HX6FZN(FH175NR_$[2BO&=-_:X^'&HW2P-
MJ5U9[C@27-HZI^)&<5ZYI>J6>M6$-[I]U%>6DR[HYH'#(P]B*WQ&#Q&%M[>F
MXW[JQRX/,\%F%_JE:,[;V:9:HHHKC/2"BN,M?C!X5O?'DO@^'4MVO1EE:#RV
M"[E7<5W8QG':NSK6I1J4;*I%JZNK]NYST<11Q*DZ,U+E;3L[V:W3\T%%%<EX
MP^*GASP'JVF:=K-ZUM=ZDVVV18F?>=P7J!QR1UHITIUI<E.+;\AU\12PT/:5
MYJ,>[=EKHCK:***R-PHHK&\5>,-%\$Z6VHZYJ,&FV@.!),V-Q]%'4GV%7"$J
MDE&"NV9U*D*,'4J22BMV]$C9HKQ%OVQ/APMQY?VR_*YQYHLVV_X_I7IO@WX@
M>'_B!I[7F@:I!J,2\2+&</&?1E/(_&NRM@,7AH\]:E**[M,\S"YQEV.G[+#5
MXSEV4DV=#1117 >N%%%% 'Q-^V-\2)/$'C2+PO;2_P#$OT@!IE4\/<,,G/\
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MJ2DZD5*3:3<G)7;;>^Y\K?"."[^"_P"T1J/@"*ZEN- U*(S6T<ASM.S>C?7
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M^2G_  X_ZZC_ -')7U-7RU^UE_R4[X<?]=A_Z.2N/A__ '^/I+_TEGI<9?\
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MZ&S0?_ 5?_B*[?[-A_T$4_O?_P B>7_;=3_H"K?^ Q_^3/>:*\&_X1KX^_\
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M*\&_X1KX^_\ 0V:#_P" J_\ Q%'_  C7Q]_Z&S0?_ 5?_B*/[-A_T$4_O?\
M\B']MU/^@*M_X#'_ .3/>:*\&_X1GX^_]#9H/_@*O_Q%'_"-?'W_ *&S0?\
MP%7_ .(H_LV'_013^]__ "(?VW4_Z JW_@,?_DSWFBO!O^$:^/O_ $-F@_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY+>S7WJQG./,K,Z.BBBN8T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
IBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
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M8?T<O)TZ^._\.>D#_%U^QJMW/-"88/]MM*"DLYZQKAT]EOW+'/C?YY_]&W/
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M188>R_U9X@_G2OUU!^6Z\?'R]U&Q$2'8Z:U-U=8O:T9[>@KO5ADG0@0!1/T
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M]1NV3)IWFBD_-!BG7L&R%?JIX4V%:^H\/.+QN,-Y!M0?N-#/0S\3[/GGS#F
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MU/52J=H(K2*/0>Z% 7/# TWEQ?=Z:TL:7XI3D:],\2 .%89$KY0*WT5I]?=
MY-N'XS#!+NHQXMJW;$_2 H.OEN^CGK'"+-3=88+=.TRP!X9($>PNU$#A\&_9
MFACIT&N>%JJ\JTP;#3/_N[.N$+7E=E")!!%/M"?77KIL5QDX<H4>2M#QQS ,
M(QB$I6#',,%HQM/.)DOU> 1)H<B;)"3,$>OGE?E1SO]TM%S0;+$CUG?('X;L
M":I@?VU>LG3=EB6K#MB&$TPPO!'M7?HN<#;^+MJ;VHOJVE3EI?\Y>>SDNQ84
MC-J]L0=DZ.A5:EA1_9NB.Q'_ON5S%'7!GM>Z+T=V.F*3XG+O.0;][<[O)HPU
M4"T)PVF88/<.$^R!(=($.^\"SRTQ.5-KN9"NQ=RHV72B?.#L,3AC;GTTKX,*
MZTRHUX!SC3Q/>W6YY>$6\DWMT=KV;7=,:L#NGV$8QJF$I6!W(1=7<Z$<<4.A
M-D)S(V%A_\V!6+^NEIQW3S,YK\(H.:_-2CFOU]:@"75W_)\CV-]:D"+]=QV2
M]0<CPP@L;,R:OUU[ME/+P(O0>(P>0I>;MI\AB?LS"W0MY.'%):3+[ 4[I%JC
M"6IL%Q7/NCN*NF!W.P+,7KA=4RO^<T>]B.ZK7M!A@MT[3+ '!KJ.T.*//0,/
MM:_7'RS!?B:D/"8[:\QJ9RT;$KU"ZK:<(F]^.D >?*ZCME+#>XV-QW>C?A&U
M?@A%Y]WD/0@7APWI08^\U,G9*\=KS:6\JO$6&F\81F ):\'N5H_/*T0W5]ZI
M-$B*EVH>-@MW@<;E)\7Z$YWDO/(CY+P&\QVQOD7.&[@KZ(+]XI%Q\N'B5!D1
M<UBV9$2&$5C8($<83R;&GQ?%O"B*@^BD1W9"4D:^KT-#X7-R-9J%7$-$)@9)
MQ+U??HZB+M@)79WNB,R&;:;)HR]WCOB^Z@4=)MB]PP1[8* 5+(>\%!CU9\\(
ME6#GW2"$?']RIJ9>L>?@=2>\O'/O^=*XW72-(/CXVRBM,/_T&]WE@>?:RVV/
MMI"K[FZD0CX<BA#C-&)^TTIUU(0U5C7>,(R@$-:"W84-=\V&>.DU>(GFZ2).
M6#0C1E1PG=?6E/-*-,D3ZRV7R7D]-P==J/\BV$?$RJ=+#\CD?4=D1V9D&($N
M"$RWDCEMCA!'##R$D00>;8P^/";_O,7W\$9W_/VFVNJEJ-U\LA9NS"_<1\3
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M7?K9@8:P>^R<_L.7R1U/M/+[^@N[8#\;B'@\[H.C5VJN.^N]O_GLO)L<%'.
MX\^:81B&D1\B6K#CP>/DF=!IQ +B@]/.&QYHZDEOZP(-#)/KPR]G_=1QT? 8
MN6=*HGRTY(!,BC\2LN>&4, +O'9CO HD1.8/#<:I@4OA*PQG^J[FA:[ES^ C
M)/Q&QQ"A:BO"?V_L@;"N&H]1CR>R8I41F@OGA1'V\@=]I/O 1>HY/Q?DN1.-
M@%><W#Y??R\5Q:^[KXE\63-:<PDY@ E&A -SB$&>?.G7NJ@X\.>0KJ@)=MX-
M!"!>PO>^&.Q7WW7N.VMN\XXSM?@2XB)84-.D^X"%&J9\@Q\A_2;8O2/<!'O6
MH>,JUKP2["6?;J==+\9/VZ@'1H&&W[%Q:Z)VURA>JOG_LW?><5)4V1[_IU%1
MU^RJ*^:<=7WFM.8UK+J&->>< T$1!1-@!D01!$1$<LZ2)"@Y(X)D&"9G)D?.
MN]]37=",,S#375W=,]S?Y]VWDGJJJVZ=>WXG_$[$U[][$O:M6L6W?&6*].PW
M1_=6)#:/Y0ALOJF!<BK++"PL+**)>DW873@]2Z7RQ^I4)>V41^.\N?.9(SW@
M=KGB/+/NKGT&),AU4]+DW:4Y,B,M^IF!FL#AB<HK"J^(PE#*?:0'CA2+\2[L
M 7K*'"7R^"+M#M$4'5'(2*K;'NX>D=B;N\Z\ZA-Y[)5^TG?HPEHYD9 *G R4
MW"/IH>??7GQS!_G@BPFR<7.V#W?0@:MY,'KB<G68]HI0 7AW(^Q<)V.4&.E'
MD#/<ZU.Q.7/OS[SR$^D]<+[:83^K6P@.($9)2U0D\^,M8?<.\4?82U3TDL!P
M),')4%OQP/-]I-> >9*>N>MJIDB!/:*2"'&SXR_\,.+K]XNP<]9AI]T5:VD9
MKH?WDY%QC[W2=]OXM_!MWQO:AD4[$2*$%A86%M%$@R#L;L\2F45ZH+O_-%M[
ME2+MRZS5J@>9=7?];6""W/MKAO1<FR_+<F+G_/&\%BU+E)Y]YVAVCQYN+T@K
MBSG2$"5ZN7'T<';B*=-.&P>".!##^Y_MK26.D8BEN8N9YV@YC)N\0C,)NP*C
MO"#WO">1]- ?<_X'&B!#I9\LEE^@3)3L*N/(+KCQBXA'.^YNA)VV!<:K(61%
M*TFXUT>6B2J+B_[=00:,6*3?W\_W#<+$NW[.U9]&U)=J";MWB#?"CJW@_GW5
M?8;JH$3Z3#1(>5,':6OV'=5]T18Y);C-Z#)&;WHA4.H787>UAM"9X/['0ZL:
MCXI6-%HHSS2VE;%OX=Y'"/O>Q[10!7I+V"TL+**-!D'876@$M;)2#U'ZO9YX
MO;^<>^UGZCC4MK2Z3JM)2&;]X?A2@Z]N'3 H05Z8ER6_I!;+Q@+_QM'\]3F)
MS%NT2;[M-5/^\U!W3Y7]^2S(&Y_[3:_?-("#HP!1CK5ZO%N6AR@;V754K2$[
M7E2!7'OW-]*YYPR=45\;(22<EIY]9\M#+_2)B.B<>'%;N>O)7EJ*7Y?Y[Y$"
M1W!#0I9T-3\7T;Q([]_N1M@A0)LV9\OP<<M4U#'<ZX-0_OWT=^2J.SKK9_D)
M @/LN3<_=-HZ(@GZ6<+N'>*-L/-,(.W=?ISUERDCX2RT'M!\>.FM(:H#4FH^
M.QI'BYL1IG7IE;>'Z0C;@SQJGXHF87?'K^6:LPX]"\KY5ZQ.U7./LRG6Y_":
M]>GRWF?CY?+_=(HH ,*YC<@Q(G9^VSX+"XO=#PV*L /.@CSC,#.K?<B8)>K,
MD0'TXJ#>84&R3C2'Y]6='++^SK2XS:RS&.=VV)#-\MZR7%EGR'I.6>PBW1S8
ME$_/F+U6!6 HJ?6R=8'G?/(E[70$#F/.<, 1M7/G/L<"SLBZ<G4^$=:[YZE>
M6OT!48AD7[H!BCL?_UZ_)R2V-J)O.%'=?IRI6?Y(1.^H:+C]D1Z: 8J$Z-85
MJ>GY,GW66GV^7O1U[HZ$'9V'86.7&OOX;=C71R 4<4C4J[EW?@$B0_!KV8ID
M>;;90 U\13(EP!)V[Q!OA-T98;E5IPF<<<7'2K(B:9_AF3#2Z^XGO]>6'&QN
M-.:Q\YVI(!DX8I'<_,!W<M1Y[T4T?]U=T2;LD'+.]\DS5FM[VANM1TBK]F.U
M=_Q/ ASF?(IEU=N:]1DZ&0.;%4EU&?N 49:,11T]T8K.65A81!<-CK"'@E[>
MB=-6:7\M&2"<ND@)DJXFS21P_%L2^&=;"3P^2 (?SY% MQ4Q)^4UK4;!<O@3
M1B;*-ZOSI-0<EA4QCG+3ZXHS@DIZ7=3@Z[)XSLQ>;?[^2(V IV<6.-GV\@K?
M1K_AF)#=)]M Y<=W?6:IL!Z]B)$(WKB+DN1]C&-,:?NRE<GZ_6KC#!'00JSK
M/D/8R9"&^_-QS F(43& $K-?@!3U&31?GGI]@ ;C(KV/7A)V'-8)T_[4JH=(
MKXLYOQ]WGBP+EL8G82=8A/ 2;0D#1R[6]\H/T\([G)"8K?:=X%>D]]D2=N\0
M;X3=1;^A"^5"LT\I@_9B#C=J\?3%$SC$OGNY[PEJH\^P[(]D^?3K*7+J9>TC
M;OMQ5[0(NUO)P"BU*8:LM^TP22ZYN:,*_6%?'WKQ)VW!2<\JT.<9"Q>$^[IJ
M;;JVCV&S(FVC07L'P4N^EX6%A44TT: ).X?"ADU9*D#V9=>IZHR=??6GX9?(
M<U@>U5P")QLC?VUGAZRWF2&!KH:L_[ VYL1\9]GUDT8ER4U3TV3@QD(EZ['N
MZBX+CG2#P%YSYS=R0@0*SSM;]"PBBO;(2WU5Q7K(Z*5*5E/3\Z(>Y<<YH,^:
MLDD$WMIVG"AW&W+!=SWHY+<]J2J ;-,'W^:S\9KI@<C4IN20DGA&X$5:$G_H
M:>;G7_6)5K*L79_APSUU',/Y2Q*D9=LQ<N7MG76T3J3WT2O"SO<G@\2D @00
M([TN'/4VGXY7<3CVK%> _$%X1YI]&4E)O"N\=,85[34 Q/0'@G'1!K8#HD0&
MCV!LI/?9$G;O$*^$G3YCJJX88QE)-8:[J"ZZ[9$>TJ';-%EM;!_:)%[8/Y?X
M,L&!0"C54Y1N>U4AZ#5A=\7E&"<Z<]X&^>['62IF2N;9;57AG$)=__DW!ZM8
MW_)5*;[WM'.-W-<%YNR@LH\9Z@0;P[V/5%G0UO;PBS^IO;>PL+"()AHT87?!
M08IP2[]A"^6^9WJ;0Z3-MM[A.AV"1.5/>%L"%WPL@:>&2N"S!1+H_F?,"?FN
MUCX#$^2R"2GRVH)LF9RR:T$RO\!!SSB^IFU&:B;<TY:%*HOR<XCE<\:1Z&OV
M 1E+G& <?YS!TK)R=93"=;A<(@EAQBF M-!G3>GYB)]_U[%U"&/]W9!C+[([
M[CKETK8Z@[J[<;[JDH$EB-!WR )YXM5^$0DS4AD!:7_BU?ZJOLN]C"9IY_[F
MFV<&J;KCL9[2Y%QORD2](NRN\TJ[!X3#"^>ZJ=D[8R>O\%34CSV:G+I%[R,9
MHDBODRH'^D(7+DV(JG(V]Q<G'W) B>V]S_;69Q?I]5O"[AWBE; S G)[T#Y\
MHN8NOA_!SD=?[BM3?EVM=B,2^^?:#LZD5+._!XQ8+/]YN+L<<_[[GE:@>4G8
M5?"WK$)'YV'_.WXW7<7QJIO8 '%G>L]]S_XH0\<NU0#SEOQBWX0J":1R1E*5
MPPA4]D D9S%Z I?>TDE>;SU"M7(L+"PLHHG=@K!SH* @3V85DM+LO9$:_:5_
MJ59C/7 ZB,B?UEH"-W:1P-/#)/#!3 ET6RF!WNMB3LAWM?8;M%T=?FEV]+-?
MM04.RLHU:3K/]A'C]'" >E$F7MU"* CGZI_7?:YCK%Y\:XB6&O\P<)Z6+S-#
MG(PCBK;E=2#NKI.%PT(&](]5*9KY0S&[0]=ITO2]$7+O,[U5F.9PL]^XCDCZ
M)ZLNRC+;=9JD521<0VU!Y0G]ER^U'!K12#T<'I[;]?=\JZ).9(4(5'@-=^XZ
M;07TA],3R;,D\.:%H*17A-V]UE_GK--2\TB#4$W.;2/W//6#*ERO7)WFT=UT
M1:&*(A[KYBXR:'<]\;UQV*>IXQZMTG@":SCZDZ:ODI??'JH]_I&T=+C+$G;O
M$*^$G7?RK8]&ZPA +Z:2\&RPYTRC<3/') :HJ@HG<\P84C=+W;GGK_+H*WVU
M)>; D[VQ<>[RBK"[[3^<X9QWE)DC]NI><]6?2U7#P8;D$C#AW6C?:;*,G?R'
MK%J77JO))I& ,YKS>=R4%?+.Q^,TV[_7T<TC.HL)=%/]0(7%LA5)4;U^"PL+
MB]V"L+L@.Y=N#D145\EX8K0A*QR\-98G8]"U#+Z5!"[]3 +/CY1 QR42Z+DZ
MYD2\-HO^]8,,87]C88[,S2R5I*)="Y+Y"<TFF(/T_<]_UF?AU7BW72V$UG L
M.'!Q-!@Q1UG;\C^3)2TS7_4/<"(@GQ!ARO="%[_/RC%_CZ@]:K@XEH-&+M8R
MW<=>[JL]<F2 HS&A@/V* T0V@_XY%+]K(S;G G7M7^>NDS<_'.79;&*F,C"=
MP15A<DA;9*S-54KF\_+RBS63 8%!!R"24O[JKM\KP@YFSENOY;=[ZGSX\)\_
M#B[["'(*N<:IYSGC++L5(2S^VUE.!IH@95GP[U47?-),=7 F,0&E2*\3<D;Y
M/ON1[)E#,,N#\Y>]V0-NANR77]?()U__HD%7KYZ_)>S>(5X).WN]<X\9&ECR
M0FW=79Q91Y__OO9H#QZ]1):O3-'^<ZJLL%NE(>^B^W[J.QJLQN*=YAQ,3,[1
M<NVOS#7><.^W<O0_O<VLNRM2PNY6DW$^(BXW?/PRM?T0\=K<5_8TA)YQ:&^W
M&RLC?_Y=UICSDW.5/>Y5QGW'LZ-$G_][G_TL5]_Y=41!:G>QQU]\:[ Y,Y9H
M -S"PL(BFMBM"#O&F_)XQ+$HQ?Z\RU1U5NF_/.34:OI@<3:.,0?F&8;0W-S5
M(>MM9TN@QRH)_+@^YF2\-F1]W[X;Y=A!&^7C93F26%@A^>6Q[E[?$6XO.X)5
ME!:>=^WGGCLHU2TR(V3F3KVLG9;CW_K0=]K/_6SS09H51WT<XDT/(=E-5-"_
M_6&F.J/\-U%UQ(!P )J_/THS]H^_VD\# *B#,VH,L1VOQK95752'G'_=YYHM
MH.R>;&E=A/0@ &0V^([T=$9Z/=Q+1BB2%>K:>Y8&Q>AGQ@&+Q/G"F4U.VR+S
M%B?(CX/GJX @O>&(]O$,O;J?7A/VV0LVR'\?ZZG.?"15(SCL9-GITT:@D3Y<
MG'H"-&GI>9)EB$%F5H'^-R7N_#XJR&3CR?;A"%>7O7(K0] R8,_CP$9R/_F.
M: F<8T@O;2?H(W /R!CR#,,%UPCQ82\1K.D]<+Z\]NYPN?:N+EHJ[-7SMX3=
M.\0K85]OG@O/]H4WAT0T&:/J:FSV#@04+1&" 53P$1@8-&JQ3)NU5JN.>,_8
M%[R?D+O5QO8N69ZH@3VNZ8<!<[52ZOD6@U3$$YT3)[/N?<59I(2=\YH1;;0!
M(+I'#S?)#S+.M0DP<![ROF'7+KNUDP8Z6G\Z3K[O/U<_DXP] ?-(I[KPOB2E
MYJJ]_&G( JVNX-YRWD62&&!/$X3'=VAOGMGBW[T5!+6PL+"H#KL587>!$X@#
ML'9#YK:(.^(A'#;;#DBW#/Y4<[!?\:4$7ADK@:]_E\#W\3FVK;JUAUD'_KA6
M3O]IM73[/5,C_<RICS= 'G!>>@^8IXK/9(ZCX:C49O%S&QLG&4),QA G_N*;
M.BJI_]<=7ZO(&4X&#LH95WYBB([30[UG$W^NUQWC=O:_/I5'7^HK/PU>H,Y-
M74'6@?+_KC_.E),O:>M94 %G\*XG>LEG77Z1N0LW:28_=TNQDB[>.3?C5'7Q
M^RS^#@2/P!H9%Q2'<=@)EI"]I02:((C7]]5KPCYO\2:Y_]D?E1AXD26##-/^
M\+PAUX@Z39ZQ2N8MVJ2EF&2.YB].T%):'%Y&#"&N2+9OXK0_=_I]UFW,T H3
MU5?PH+0<DL:8/6?4WPP=1Y>8G*O/,IP]@/HVI&*.^:X$R>XW)-B+GO6J:SMA
M[VL)>X2(5\(.J2*(13475471"*3R??ELS@GT01 :[=%WMKZ+XR:OD%]^6Z/O
MY(CQRPQ)GZ=M4Z^_.US?%X)=V+9H:KFPPB7L;L::P"!M7Y2T<Q8RVHR@1;C7
MPW<^]?)V<MLCW76B#Y,K"$+3QDBP$3N /6#_[\QV\.>NW: :"[M'D ]A6]=N
M''1*Y&<'/@)B=1?]^TL-!/!N1F.LGX6%A44H=DO"[@H705B(OM+73E:5,EN=
MUPY9/.XM"9S]@01NZR&!E\=(X.-Y#EFO!YGU;1GV/NME[T_F2I.W)\K; Y8H
M*2;C%8_@NGY?D2P?=9@H%YJ#T(LR[? <+O= ?DM)$L2=:\$!96^@+(OR/!E)
MR!B1>LBZEWWI.UN0OT/,=9')Q^&#K(63P<3QPL&ALH$20;YG)$Z7NRCAQC'B
M76+4W#OMQVI0K(]YQRA]I/>87E*RKY!:G'&R3#B D$W$U7!N$11CL@-D\LG7
M!VAY.2T,W',O%)ZK+H(S]/,/&K5$^^0C!9H(S <_R3C'7@08(#_L00)%B,0]
M^'P?>?R5?O+T&P-TM!VB?U2H\/O_>^H'%=?DOC$9@?>^)O!=(5A4 U"U$.EU
MNIEV2#OJ\\\T':B$T]D#\V74A.4:;* "@V=?=0^P/R#,[($>?>?(YUU^T;:-
MQ\WW@\"=>=4GG@06JBY5NK_R8PT*H:D1+BQACU_"CIV$!';K/5/?(VQ5- +#
MO.^<$P2 L*VW//B=)@5X)Q\T1)E]<<^3O53X##N)O@GO"QGJ:-BVJBM<PNYF
MUK'1",52279T<#9\),$/@F78C),O;:N51 3MGVL^2-[Y>*P&Z7KUG[LMX(%6
M"[9B[J)-:CM8D/)I,]>JJ"#EZ?Q]*N,HM\<V8B]=N^%%\)3G>]ZUG\G3QK9Q
M9O%>^C4FUL+"8O?%;DG80P%YA[A3(L]HK"O-@?&W4UK)7N<8LG[-5Q)H.B$X
MMBW^Q>5V6'TW.@&&U\?+?G=TEP=:CY8^@^>K\)Y?LY+K"IX%#CU$!R=FI]H"
MN^'"^<6Q@1 STHR2]DA'"4&0'G[I)SGK7Y]Z6F+N]MCCT%&= !%ZN=50+7W\
M[)LITKGG#.G2Z[=M[064YJ,R3N ,HGGK0]W5*2(P$HT^SJH+AYE11/V'+]*L
M?J3@/:,T]OSK/_=D[%Q=%\^2LEI:?G8V<@A%]^'CEJFF!P3#Z^O &3_N@@_E
MTEL[R3UF#U#%P)@Z'&I(/)437W_O[ $R=K2B-#7WC3T T6$/'''6NY[-H*YI
M$:PZY;)V<ONC/;0'/UQ8PAZ_A-T%@4/$T7@_]O8@2%G?5KB$'3$]=]0<@I^1
MZE[4M-R2>=Y[!/UN>[B[L0?]I<4'HS2@CZU@CS%&DC.DTW?3-3!)R3L!0C+U
MV U&X=5*5+@.B\ \I?SW/MU;]R85&Q86%A9^8+<G[ !'B/ZV2;^NE@^Z3)/;
MF@^3$U\=(8W>^-D9W=9KK03Z;(@]":\+66<N_-?+)/#H0&E\03LYY];.<O^S
MO545'37T:*NRA@MZ^\BPO=)JF!)3+WL-Z_/".=K'.!^7_:>3.B8XG62+:CMW
MO2:0H4?+@9),QK-YY]@XI?L'G/26.N^G7]%>Q=,H%;WNGBZJH$[6G"PLCOFU
M=W?1[,HEMW149XLR_2.,PZ45##ZT1YQ\23MYIME +7$DBQ0I&)M'$(+OU\0#
M@:.ZKMH2=DK5R<#CO%][US=*$+VL%N'9(41UU'G.'J!ZACW 5 'N3>@>(&/'
MGUU\<P?= R==W%:=;LI/HUTFS/<^^=)V.D9KR)@E83]W2]CCG[#S>91>L^^J
M4S-OZ"M<PDZ% BU.9+LAT=$*ICH]XD[9^9'GM-9@*O;@4G,V4+' ON#9D3G'
M?M"7CNV@/)]  J-.(?N1ZH=4]RZR7P@B$"!@'\5KQ:*%A47#@R7L09"DS"PH
ME8E_I,G[$];*)0-6RQX]5VM9><P)>%W73QN=JH!V<R3PG^X2:-),#T R?:^T
M&BK39Z]5TNZ%@K/7<-6@^PY=J&6ZE+*1_=J=,^TX,)3H_^/L-EH"/6/..NTC
MA*Q'"L@IU26OO3M,G>S=]3Z?=$E;S>KV'C1/E8\C!4KYE'0CJ 1Q]OO[U):P
M.ZU!16H3".@18/&C+#?>%LXX1 82 "$)%Y:PQS]A7[\I4\=[,7F!@%!]L7DN
MD8VTVB3\'G9C+RHJM R=@#K$%9_"KW:P6-][;"IM0VBTD%0@@('JOX6%A84?
ML(3=H,P0U_222IF77BP?SD^7ZT=ND&,'K)=&]*O_5(\RZ^[Z<9T$/IHE@:>&
M.()YFNUT9L8B7/7:.\-T!G<\BJ6X(V,H*6:V*WW%YP9+HV-]:,=BN;-^+[ZY
MHSJ8_88M5$))9M2+T3<(PC&2CM)",A3T47J9E:@O"W*+VC$D&[(=*1A52$\E
M?92H1_O]?6I+V%T!SA6K4^7#+R=HE4,L*@)BO=CSE.[34XRN0[BPA#W^"3OW
M<NW&#&W)H*('_8[Z8//(.--B1) ADE+^2$3GL!>T#-&Z1J47K6MH 33D()];
MHG^"(>OHAC "EE)XK\;/65A86-0&NS5AAQPB%9)7OE66Y91*G_4%<MNT=-E_
M4((T'I 0>^(=SJ(<GAGQKXZ5P'6=)7#6^]L.'B+A"*8@A$4OV.KUZ6$IC/L!
M#D,BV(B 0:2(YCLJ_O4C&Q+I<DO**<$[^KSWY>DW!LJ$:7_*1D,FZS)O?5=P
MG; )AF PUN[,JS[6;'ZT2Y"]OE>17B]D[;YG>VM/-80K4FS)+]:@$Y\'*8AV
M#W;555O"[H+23I3ER9S1R^[W]<;Z^6-7F'O-;'>"8N'"$O;X)^P NT=E$6<+
M\\-Y7^)UO_,NL@_HG:9=A.N-1,@RTK%N5'81Z)TP=:56$-%.Q#E5GVQ&;1??
M9^]C6JA@'<','C_-UK%\S'6WL+"P\!.[-6$O-40EL;!<9J:7R*<KMLA=,]+E
MM-%)AJQODCWZQP'Y#H>L=_]3 I\OD, #?25PMB'K)[2L<O@XBJQW/-I3YXBC
ML%I>$7^18JX'TLX\:?JU$:IB5CJS3QNB8U!U.27PK;77]ZV/QLC@44N4"##F
MRFM%6IS7/]>DJ2CADZ_UUSFU[)/Z4.J((TOF"8<[DE[W8\UWOOO)7M*YYZ\Z
M[C%24+D"":9T$H7HVLXH]FK5E;"C ,VL:,@J:M9D\B*95>S78H]R7WE?(LF2
MLG<8T4B5"3H&X<(2]OI!V,'*U:GZK&F%X7K91_%H\R"+]'#?]D@/>>'-P>;L
M[J%5 >%^7J2$G3V.?2/@SZQYQ#5Y;[@F/VU<M!=^!GOX1&-'&=')"#[V8DYN
MD:=!<PL+"XO:8+<D[%IV;59V::7,R2B1+JOSY/HI:;+/@ 39LSX2=7<AC-=Q
MB03>FB*!&[Z10 W.!\XIV22-&/>=+7D%)7%[ +D98$:Y,.()<31$K/8][LV@
M2FWL#W8OES,'OKDT,83I@AN_U+%F\Y<D2+HA?P0PHH7\@E+9G)0CW7Z<*9?<
MW$&#.GM%2078*V<*;0,R.T>9>X7(4"1EHKP/:"9T[#9=UFS(\.2>LG<1=$,W
M@K)X2D?]NC]U)>PZZM(XXJO79^B<ZLMN_4HS>O$<''-+51&F), 02=:1]^ZP
M,]_5=PX=@W!A"7O](>P$J1!1^[;W3"WMAA@[HHOQL=_=S#KC+)GDP12;KN9:
M7VTU3(.JX7YNI(3=A9MIQ[X\UV*0!A5X%[T6KO1[N=5MV%!:\:Z]^QN=Y8X@
M;FZ<BO5:6%@T?.R6A+W8L/7U!>4R*:5(WEN6([=.2Y<31R8J66\4:](=27:]
MUQJ'K-_52P(7M-_)@?2&$AT<>OJBR0)Z15*B <@$\Z)QW)BQVK3-"!6'HHSY
MX%/]'YD532>!^;WH##S;?)"./&/.:W)J;L3CVW8% C:4<3,?^Y/.4W3..[W,
ME /&H_-%QAHGFZH+,L*HS$<R40!RBN(PRNXHO'L%1/W(XJ% [V=U2#B$G?W%
MY('),U9+^TZ3S#OVG=X7LM>Q?MY5%Z2 "A3*]Q'+@\0P6SO<SW/;3R!']*B&
M"TO8ZP]AAW 2J/QUSCII;]Y[JL[8[_&2:6=JQUE7?2*/O]I/?AP\7RO-^@Y=
M$#>$W<VTK]^4I3Y$.V,S[GGJ!RW9/\C'X*37B^?/V7>Q.5^>?W.PDG6$]AAK
M%V^:/Q86%KL/=BO"#MTALYY14BE34HNEW?)<N7QBJNPU($'VZ%]/>]:W9=?7
M2Z#;"@D\/D@"YWPH@1-W?6"2G2++SGS3R3-6Z0$<;Z7Q59&2EB=+EB?)IU__
MHB2-V<F0$[+2#AF*_8%?E^5F4?@.!YW\MHZU:MIFI P;N\R3L6UU169VH?9>
M?]EUFH[@(NNT=QRI]),)Y7IP"LGJX"12JOA"B\$J"A3NYY*A9V00L^!7K/)N
MMBZ]CK0;?-]OCHX><DKWXX^PN\ &<,V+?M^L@GD$12 Q[-%XV .N4C9J]HQP
M>A#B\>,LU6"XY\E>$7TNCOIQ__>A9C'#A27L]8>PN\#.+EN1K"UB%][XI1QV
MQCLQ;0ER*T=.,V?;_Y[^0>>-,]5EPZ9,&65(>[P0=A?X#!#9WU>FR%<]?I7[
MGOU11S)2!>=.>(F7JH5=V17NNP:#S=GW7/-!,G;R'Y*>F1_5_6=A86%1&^Q6
MA+VPO%)6Y97+R,0B:;XH6ZZ9G"K'#$_4?O5&];T4OL-B)[M^2S>'K!^SZUXR
M#JACSG=*XSM^-TU+OH@BQS,H8T2!>_:"#3KZ#67KQU_K;\C6-]J'3&0_WIT#
MUT%@T?='*2$9;7H!(0N3IJ^256O3573/[P */S,]LT"S3IV^FRY/O-I?KX_K
M;!Q!R7FDRRV!/_Z"#[2Z C(Y=.Q2%8YB'[S>>K@ZHN%^/H$)R.F;'XZ6Y7]Z
M1]BI7" (@E8$>Y5K=\?G17.?ADO8V6]<,X$Q@G@=S1Z@'!=R#)&)]7N#0\U<
M9NYCZT_&ZQZ T+$038SDLYT^]C:J'DZ@+)QWSQ+V^D?8"XM*56]B^NQUNM\?
M>:FOG''EQ]H6Y*?(*0$"]N"QYDR^[NXN\D;K$=)WR )9N'2S;,DK5L'1>"3L
M!)39]Q#;!4LVZW07VFH0]+ODYHZZ%[!'L;8=.WOOT>LX_H(/];Z35>?L8\H'
ME8?LCVBVHUE86%C4!KL%8<?M*C?.5VIQI8PR9/W-Q3ER_OB4V!-M+Y:6PJ^5
M0*NI$KCO)PE<5/<14I2\(KS#J+<UZ]/C;C9[35"Q-$-L1_Z\7%JV':,*SR<;
M9Y[O0[8,@N?VN<>:Q+LE[SB 5 /@P-!S2QDO1 ,GEWYG>M7C8;:K]G<FY\J@
MD8O5\8*T'W)J*[UV/[4#7">6^X4#39;ZTV^FZ-SPS.P"24[;(I.F_ZF]_A"Y
M<'_.P:>TTCYS5-)Y#EZ#+-[T6>ND?:?)<NFM'54H+YK9)^X76:[[#6F<.G--
MG:\7$P!Q9X0@.A>/OM)7JQHT:^;S'G#>F^W9+]H@"'[,G+=!,WMH<#"6[HG7
M^D?\L]AC7WP[59UT2'M=80E[_2/L+J@L0<?CQT'S-8!*>P1M$M'.$KLVCOMU
MH#D3KKS]*Q59)1B9D96_[3S>9-[%>"3L54%P 4$_!.E>:CE$6[R..O>];;;#
MK=:)U9GLGL5<Q]Y!'13N)V<+]WV\N>^,KJLO?I"%A<7N@=V"L!>4;Y6EV:72
M;T.!O+P@6RZ;F"I'#DN,/=GV@JQ_OUH"'1=+X(G!$KCD,PF<6O<^7@Y1QL40
M6:87#2?8:R7R: '2MFI=NI*2/H,7:%GC:^\.U[YF*@=.N[R].N$X0[%P#MP%
M0:/G]IQK/I4;[^VJ!(@L,<[MB/&_RX(E"9*6GA?U7O7:HLR0-1Q8E,/IG83$
M4()^X[W?RJF7.?<TFK.+7:>*GT,?)R3MC38CC),Y6_OLZ0UWJ@'RU:%OVW&B
M.MCA/Y^W5#^ .;L\"Z\! <0YGOK;&OFRZU3].62?<&2]S#ZYI9T$5Q!0>_&M
M(9K=KRO<K!DB2P0PAHU;*I]TGBS/-!VHDPM.,WN G^'%2+6=+?88)/U,LP=0
MQV[^_BCIV6^.[H'-R;E2$:P(V)"0I?:K<83M&WRG#[Z8((G).6&-;K*$O?X2
M=E?'@_+XP:.72-L.D^2QE_MIF])1P:D)7K:%N#:.ZAZU<0]^)Z^_,TRZ_C!3
M[<2Z#1EJXUS4%\*._T" $M).JPJCT"#"3[T^0/Y]7U?5G:"2)=+)'N'><_8E
M=I<@-/<<O1C&W#(EA4#P6O/^;K'B<A86%G&&!DW8-;-N_E]B487\9,CZ,W.S
MY,PQR;$GVEXM2N&_7B:!-M,E</.W$N#P"\-!<D7H3KZDK9()2'"HHU"?0,:5
M_EM$>BAO1OG[S"L_5A$92#.'-=EW(NLX]SC$. TX3F[4ORY.INMTN5E /H_/
MY?/Y.?P\R""M!Q H'"6< T@ZC@&.>#P0])T!\@9!)N-#S_AM#W=7 H4HDGL_
MW<Q)=?>RZOW<_OMO_/7>'>W<.YPYLDT\._HX/^\R5=7R<01#)QIP__Y8E:("
M??]WPQ?Z[\)9M%+0JPW)FKMH8]2R*U0NK%V?H<__I99#E;0??=[[U>Y+]WZ&
M+O?WM]^K%E7VVIM:+< H(H(<E*8N6K8YXNN&,*W?E"D3I_^IGWG;PSTT&$:5
M"/=/K[N6>R#T]W:V!_@^$&@<?/8 1)#R8%IBJH+?HZ4$X4%L6;C[ "(!05[^
M9[+NM;H"PN[>I\=>Z1?V=;B+7GT"" 1.Z@MA[]9[IIQBSA*";=B^<+_[?XR=
MH44(P2\_O[L;K*)%;/#()1HDNOP_G53DE+WEOJ=_W>MO[+#7J]_C3;>=#VKC
MS.>==95KXWZ1>8LV:955:37B9O2QCYWTA]GG([2_/=S[2KG_8Z_VD^_[S]5,
M<K1!X&N-L7GC)J]0,<N'7OA)+OQW![5[SL07[\[DT/M=G3TAZ(*=O_263MKZ
M@+]#4(%*HG#;8"PL+"S\0(,F['F&K<_/*I7OUQ7(4X:LGS\^60X?V@ RZZR?
M#%GOL4H";TV6P-U!57@.M3#*5-WY[/2H/O7& !4\^]-#I6P_D5]0(BG&>4<X
M#85U,B6(4J'^_>:'H^3Y%H-TINHM#WZGF1-*TB$>]+\SULD=&;>K[+&6U 5[
MW_YN[AMCP0AX$+7G<_E\^H>?:SY8,^F???.+].@[1XD:V4&4R+-SBY0(U8?*
M.S(.ZPP18;S>H%%+Y*ONTZ65^5X(\]SS5"_-NB)21Y:;X 1949<X;7/&MCE.
M;^I]0V2/OT<VCG)V^J31(B#(\K39A[0YT$O(,T2S@!%,!))"JS_X=6I&GLR8
MLTZK*\C"A[,@>_R\GGUGR_J-F<9QJXP*:<<IY+GS_ F =.\S6PG9RX:\$RRX
MZ?ZN6D)*\.&<JS]5YYI[@[@B_TV%QOG7?ZX5,?_Z;V=5MK_S\9[:ML#>AEQ\
M^.5$[<,>,'R1S)B]5OO1(P4]G 1'(*,S9J^3 2,6Z[.A%>'99@-UACW]GP2E
M>)]XIM@3@BX$$;8%=8*E[>P+W0.GM%1]A&/._T#_'=_[&K,'*$DFF\_G\UWH
M5:?R(=GL 8(>50$I&#YNF3[#YN^/#'L?\/.H*('(A)-A=Y7VR2Z2L0OW.D+W
MY;@I*W2?UY<^6O0O".H@9AK)=T=LC<\BL^SG=^>]9Z'GLG)UFFHY_#!PGIXA
M:&4\_&(?U5"@M87 Y?$7?BB'G_6NCFW<UHYUM!-$<X.![''^'FTEG ^,)R7C
MS'[]JOL,M7%4$B2G.!-!JJMPPVZ@K\&[@,T(][X2,":@C4WE,Z,- JS<RW4;
MG/.#,Q 13L[$MSX:K6<(DQXX,[%]G*'8/"J>W'-D[UVT)?#[G-G8&BH6T '
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MH_K8D_TGM/@ZDBG86?L01(C".<Y8I=<F0OVGX[.]5QW1&C8J^; P2 @IQ@#
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M>\-(L,?$>J%[[P^Z=8+G^]U:C\WGOB=:AY&JQ-]KROZ,<X*#?$+L=PA5BZ>
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MUBY2<4]T-C;/A76LH2A7_O^>3M]B _QM>DRT?^F^Q8+0VM:J!#LC%DZRTH>
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MQJWQ>6\MF?^,ZZ?E.3&SQM?S"-\CD0@8ZGSCR9 W$NP2[,E @CTQ2+"G#NP
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MCM4QGL_3W,'/V%R7 $ZDKYF2ZP\$P]4W$T6B!3M>X[7.&/QP=84/YZ=E86
M<*^$4>%]HM >T4BI)E&"G?PNBN4-=\^-XH!;VRM8&Z[Z/-=[U[]JPGU')=@Y
ML/HXN\+N=K_C[/$Y#=Y3(N;^=_._@<,J__/=('IM=EZESZ5+Y(JS9<%>+L'>
M2MB<8*>K""( L3<[A8*=&AW8A=O%.XH$U\,^0I[NO()H'3L2[ W3G@7[Y+65
M?C\AE:MS0VOQH.2O]7PKY$C3.8?YF8RI)\'>,G@E1/PN*JKVZ;O8>$29!L\1
MQP1[ZA%.=T-:"'8\;7N_O<K.&I?M^]=146^-7G*3J:FIM34Y139C]DI[J-]X
M^]55_>W04^]OL5 /!J+_R!\_:+^Y]F4;]O[<%E^O!'O[$>ST!)WD?C>]Y@\)
M%</"8\(),>D/Y)CO]79F0@;]2&/>QKJ>1O[\#">D^WQ9Z 1NXJME)UJPU\9_
M)F+\T07%OLM!N$HZ7E-"0^F]/<+]7-;JLB3FK-4G48(=(4<8(2*(''_^_5U"
M;?G"A@CSA5H U*S &&G*7A&58.<=OK6\S"Z;M*[.'HJQA1!B[G\_07,_&*R?
M.PS-V,1@Q+AB/:+E4"+U\W-.L',@1I1,6+#3L6&8^QZ(,$C%U.3[HW7>NTXL
M4$69L% &]SS6"83%;LY6)N#&VZQ@=]<\)JO<;IV=[[M5;-R35]I>(U;9U6ZM
MF9G;O$X&386W1'T*UKV@HTAP/518IN@F\ZHPB84BMX8$>\,@V$=FEMN_9N9[
MVV>C8(_5J**["0=YJ2#(*<?^"=8#!O.'=6MF7N(.H+!KW\XH]^EJQWR05<?>
M0X#M,3Q):_V0#/]LPP*>[R98ZQ.QYM5'@CTQT-YVI+/?J+]T1*A8<I>X#OK^
MB$S_]])"L&.8T52>W"A*V/-Q1;BNM5HJUU=[L?[\ZY_;15>_Z%NP)<*S'A;L
M)Y[WF/WI7V_9>Q]]U>+KE6!O/X)]D3,2\&I?_?DZ[Q7^[CW[#2S3Y]U28 ,C
M+!$#$8NA1.A].)>7_TTDS]6?Y_K<H4175$^T8 ?^&N_DL[65/OP];/P$.=Z$
M4B$>N"<\\JDB48(=L"<0WT0+X)DX\-U-J^-SP$/E>(KV4)ROK*9I[>NB$.Q<
M'8<H1(Y1$7;WD+CC_5$<CKE_; +G__$^OS'3/:M5F[0%/..C6'$[O%LUS6GX
MOAGZ+RFQ(][+\OMY6%@A8EYSZQ^ARZEH-8@1B;>?[@)X)WR7$3?(Z?S7S#S_
M;29"X+55P4X]B8_<W+AMSJ;&X\[.*+]\TEI?,"G9Q+Q/Y@]Z*;Q9_YL]P==C
M*/:1.<GL[+ U)-@;!L%.J"^ZH4X+RT&QZ(C?QRNEIP+$.GL5AU#!>L! [![P
M3FRO2@0;XE'!_W/K#_GIK/7AM7"/>)V28Q.XSC-P@O#^ZN?+$\E 6#P%EQ.=
M @42[(F!^>F?I9N'V.+!<R2*@G5WNR&K_-^+5+!C?'$:SRD4A7@&K2CU^18)
MM"':!7C6L]<6V^QYJ^RI_A/L\K^\8D?]^,&$"?5@=.[:W<Z\N)]UNVNDC9_T
M38NO6X*]_0AVA"2="VA3L6O(<XHH^[5;[#&DZ;?]^(+BA(Q'W+RAS^FUSC!!
MN'2.A^GRWW@T:7&%X;ZZHC:ASST9@ATP?E:6Q7*=KIN6YSU?80\TAQ!4WG_<
M;9Z$JU;&BRLFFT0*=BARUB_]8ZE^C[%1__DA/A'K[!=4^V_J@4NJ!3O75N!^
MWC?%U;X:++\G.$ BL@RA1[@O!S$(^D3-?P;[-2%V'.:$O2Z'N;GS*S?_.? @
MY2)1LX3T!$04AF/'T._[V2?Q%D-K*YO5<[BIL-8\$!?2X<*6&+9_FY[G6R$E
MHA!36Q7LU,*8E%-A][COX:@/-GK8.\8/6&E)27H'XB^96Q:'.WP[M ']Z<>;
M"G:\M,QAO%-E$0IA"?:&82_D4+"7$XQGA-9R['XB<7[V<;:W^9/-A@VQ[ART
M<Z6J>OW]A+:IK+V)@(/ %:4UOE,1>S)K/;GEK/7DE?_RTQR_9OBU?F'BUOIN
MLPI\>U/6WW#._&'O9?DY^=+24K_F)=HD:&N"G<>#N5(:[Z&>Z[[KJA1\LMB#
MM)K&J57'(1,OEHQF@$@%^W9Q;Q<;'NT'^*A2(5K:&GC6$>NO#I[AP]5W/+BG
M==F_1\(%>Y>N/>R7O^_O<^.GS%S>XNN68&\?@IV[^FAUA<]-QKN^7>CWGCX6
MP[;(/EM7Z3T[3>L&L/G!QHD112@NJ3:$<P8B N'.B3^>7$)G"Q(HT)(EV -O
MTQ(G_!#"''(<$,IUXID234 ('#^_T.TRJ1!'B1;L='+@T';DJC)_ %&_%@'"
MZ$]3<NU-]SW1O[VII%JP<VCR;4F5#\4F;2%H2<?@P.40]YP>=\8;!Q7%58F9
M^\&@$"%>[TOJ/<=80:(L?TC 05"BI@G]8O%B,P_#@IT.!WWF%L:[&21_3G(P
M0+K$>>-SO$,@N(X3G& G?W]81NS[:"EM5;"S_G-OC[AYB2<P_)U@0)XS/MO>
MS2SWWU)E$O<LHE(RRFI\MZ S&UA+3XEWW, [%65M8@GVAN%;I[CK?;YNQ\;W
MQ]I "A '+CR79(.=F>GF$;40.+ +WS/K X4X$<^) +$^P=E8%$/%Y@C67=9Z
M]FL.P7)\AYC:A*[U,W(K?1M8PO##:QXV]"'N]][MUL.U":Y9 FU-L/-Y<KD4
M99V;7^5SRYMBOS07]F&B"UGK3OMHT[6. 9$(]FU\P825WGC'*'O,;0RS\BH5
M"M]$PI[U?B].LM_=\(8=_9.'?/NU1(MU!L7K?O>WU^V-(3-LWH*L%E^_!'O;
M%^S!0D1(+&(5CU>G01MSUR]R!@YY;@BE1-X_Q@F"F'H8?W+&R:$CZ_8Q)RP-
MK_XP9_!E)M"H3I9@#R#/>X*[IX?=FDGQ,L17EW@Q)JHH$VK8VXDC#D@2>5^;
M(]&"G2F0O[[&M[-##%$=]>QQV=Y#\^.Q:_R!!,599N=1%;_I&VFJ!3M>PBGK
M8GF3/P^%];+_8<A?^.E:&[2BS*]QB?9^('80KQB/S)% 1..!H?8!^7*LOW@1
M$O&[^98X2.*^PM6\"?>_<O(ZWW,V&:T4ZS/6S7UZT5/H*IP.P_K;;7:![T:0
MB'?<5@4[+1)I2<5ASXEC-HUR02@_^TVQSXM-9NXX:]TT)T3P1H:+EG6*UWWX
MJ5O_R($NC]ANE&!O& Z,$9*D+?PRM/9MXX7R*CO0B3K>+2E<R8R0X"<''3H(
MPZ^_[A_FKH-<]D1 +CSI.*R#X=HAU%QA_6<>),/.8Z^GU@.]W7?W$4X9=>SH
M?\9;,7*XE<C(N]8NV&,"?8/?]WE^%+U]WJU[1&B12O#\-R7^>XFM,<F;H]A(
M."I>65KBU]>-=D(0$A^AASV6=YEAQX]:X[T++/R(A+8@S%()GO4Y\S-]B[5+
MKWO%=CKDMJ1XUH-!3OSUW8;8N(F+[-N5>2V^?@GVMB_8V?@)T7[@JT(?QKU-
MZ/V2BTP5TSD^MS6QN>0!;%(8(7B%.-4/[I?^EAC:>)$(5TX4R1;L_#L8R52A
M)=R_Z[L;#R)\+V_W3,]UABS%_68EL)#.YDBT8(=:?X\;O '\E!.Z>&@(J^2>
M>%\(8#;0YCR_5 MV/)#,A;^X9Q3.32,U@\@/C +N,QGPC/B6[YQ7Z$,_@^*+
M03<&ZDD@>&A!E(AO;W16A?=@L<YU"85E[N6^NQ-&K_$'\T02)'N5X_OB((2P
MV_"<Q/M_U[R8I[]8@GVS5/IY4^L/DDYIH,4B*1;,VU%9Y4DM#LRSX]NYN9[=
M27@QN<<X>_!F1FT?2+ W#(>5_*[A&>6^\&1]#<!A<X_9^?YP-IDM27GBTW+7
M6S\GI"^H]WYP&E(_B\.I1,!ZRG[XPS&KZQQ:LN__Q]TKWTPR0JQYKWC0204D
M8J!3*)H0T4<KT?=6E?G].I&_O[4+=B)S<!!,SHE%@C!/B2KB&6)+4226_2+7
M1_$D[]O%IJ/;#8<])X4.)]FS.=PB0@,B$>S\<BZ*DW\FL$+AFT8-HB#N67_F
MI>1[UH.QPT$]K?L](^WKQ6ML;6[+%S@)]K8OV)>55MN0E:7N6\_U!:""WT>5
M5(S!/DZ$$>:=K#M?5E+M\QSI<1DN8L8:A.%)+C05CS$N:A-P@IILP<Z_PK62
M[_0_9V3\WHDN3N^#@Q"$&05H+HE7 E^6Y(),R1#L$(3&(\X)JR07DD)81$S@
M.>8G-N=MI5*P\SGSL]B$$8O[A^8?@C;P.L\K2,[!2K6;S\Q'?C^YC7N/J%O$
MC\)^#SG!R>%/(FP1WA7K-=XT1%7P>S XJ"[.<Y].ZHNS)Y+AK2B+?WO_^Z;$
MVQ>[#Z_;MYO[Q=N'%ZPL 9[^MBK8F;<<]HQ97>$C6CA8#>?%LHY?Z.[Y4?>N
M"1E-=.%.GT?J_F.!^]D/Q*-LPH5*=XT7*:;Z>"*K>S<7"?:&X1NG.PQBF0/+
M;0=GU/D>L?$0>GR3R3I<CLVE#3;"B57N^<31=?7+D>^O]N]LX(JR%OT>7BOB
M#P_I3\9E^S6@8\C.P^/^JK-#:*>9C-:6U?%OEM^!C;%W2+0S<%@@YB>YM3X1
M:U] :Q?LV%+8)V/7E']WJ,Z^0>M!GA\V.T(>&R0WB7DW[!/4[N$@],A09PYL
M](/>S?*V*D0BV)G,?W4/!V,%8[VYQE=[)<A93Y5GG<%A +_GWL<_LKR",BNO
M:'G/9PGVMB_8\:ZSX%%L98^048O()#SMA24E20W=SG'W@B"Y9UY!G0)*+,8[
MQ$/R,;3*$A16F6S!#A3100C2?YB\-3RU'0=NS(WF5);^R7@OV 16E27O^29+
ML+,V8-BP1Y(+R7-EQ(KI-?]Z4RG8N7;"/8D,V"U4;(Z!H.5[FY-?9=E)G/\\
M*D+5\;"0+E&G+=;H-?8']PU2/R81<Y].$/RN/SK#.'RO0?]WOK67W'S%.$^&
MMX*#?PQ(GC=M8L-Y] P\LK3.X1 K$;976Q7LP-OA  8C]DAG\Y%"\9T1.33#
MWR/14?P=GF4B7R="CVP7NF)<XW['?DY\A#L=[#-BE?UZ0BR5DE#GJ)%@;QCN
ME/6:_9V"L^P1X8,?]JECXNDRM"1-QI-A7G+X^XS[%BDZR<%A^)Y/_2C;]X.G
ML&%+X'>P;SSX5:&/Y-NN7F<.4G1P#& ;),M1RX]]W^WW?_A\G5_KP\^:_T]J
MX, 5I0D]P&_M@KUV0RQU@\@(BB#N/CS#B_6@2"N'D]BNI&ZP;R3KZT4'TX*4
M&@3AVD38):>,66T_=]<&*17L3&)"#<YSOYQ3?UYV7I350EH9U6ZQS5I3:--F
MK;"G7IB8,L\Z/W_7(WK;X6<\8/]]>;)55%9;=4W+WYL$>]L5[$$..=6$V2B.
M_B#+>]J"WT=.8A">FIO$-F0(XV4E5<Y@BIT\LP8%A;\0[>1%8TP1%ER2@+8G
MJ1#LP":#0"&?G5S\$T;7;1=&.Z^?CL^VWG/S?<5G0H"3T5(K68(]6:1*L/.H
ML\IK?>&WZT/>I6WBG5$P!/ >KBFO2<B\VQ*T2J5J,?,A+-CQ6O(=DK]9ZN=C
MRZZ#>4\*"A7^?3O%4-$E!FWK,";[?U-LW[AY0SYE(J9D=5S@(1X1<1=/J%L=
MGKUD-[>7$*Z/1Y;U)A%+;5L6[+# K8D\SU]/7.??YW=":U LG/DG;NU\/%[]
MGX.IECI>@I98_"P.64E_^;%;0_E>.H="?#F,[#XKWQO9J:C3L34DV#=/K"9)
MK5]C*!RX?V@>L0]_WZ?+K+8^[O>20TST5*+J>? CJ,5 9-;?G2CG=X5M$-9B
MWA<YRS-S6^;A)VJ(]0 ;B@.MX+"0N<OA(8>(&:6QO3"9,X U$ <)42GA0RY2
M +$]^)ZQ&Q(5X=3:!7NLF.\&?SA(GC^163N']@[^-^O-59_G^NB%N<Y.+TQ@
M6E?,7JRU,?$YBAU>MXM2S+'%>@<I%>R[N!>*@?!/9V!^%F_QDH*BL6T&A/+4
M+Y;;,R]/L@NO?L&^=VBOI'O6&1WW[68'G7*?G7?%<_;F\"^\AR\12+"W7<'N
MPRJ=",#CAM$5%)L+?A]M>MY<7NKSQY-9<(;%F%-^0JH)U64-"A>#X>2YSY>%
M?E-/Q,:2*L'.M\.]K2RK]O.'?/;#0Z%4W"/?SYG.J*9Z=U:26A])L#<,(A)C
MAG>#-S XL2=,DD-KU@*B(Q(=3MP0>"&'KV2-75?'Z]QE4"Q<_?:YA5YPM'3]
MX4"(HG+/.4'.=[5[O?9N&)"DPN"U)=P:CT4BSBJX;@[^,:@XE. P)/R-8TC2
MWNB.>84^VB11GT%;%^Q4UJ8N 9$Z&*T;A4ZL12;BZZ(),>_3UVZ.M32M* A?
MYJ" ?9]\8]YE<.@3'++R[1"I0<I,L@^[&H,$^Y8A5)NN'S=]D;=)300B;[!#
M?N'V9H0FA\N)6A/1%F.RRGUQ36R0( HM+-@YQ)NR;GV+H]!(:R)BF&B!</T.
MHD%.&KW&%THM3;)8AT7.GL+FPA[8.23\J%B_FUL'>1;8#(EJY]G:!7L .H34
M#(1Y./V&_;ISO$ L-5]>6.K6G=+$I0%QF$44*AV+J [ONQF%YN@QHV*'66\N
MCZ5LI$2P=_1]"#/<3<?:JI OPF(K&D=558UE9.;;Y&G+?$LU6K<=<?H#2?>L
M!X/^ZZ?\X@F[H<=0&_WQ@H3=EP1[VQ7L]/PD1);%_)@/LOPFQF:Y;?R]_LZ)
MAX_C>4%)3+'^SFM#2Q?RZ"DH$CY!/<@9UYQ@4@UT>6GK$>P!%"M!.)"WBW"@
M4,IV\6?-,S_4;9R<' ]U:VXR0KHDV!L&@VA49KEU<P;2:?5Z$)_H##BB3C!B
M4P$G^/0@_G?<^Q,4GV-?YGK^.BW/>TFY]Y;,#P0!2Q@="EA+J.P?SF7G=_']
M4Y#I!C<G\;J1&[BX./;,O1'9R O8$"^^B!W!.D+1*-K]46B.\.WP00%&#V'Z
M'!#F)S"BKZT+=@H$DJ/^LMN??O')6E_H+?P^64?)M[QTTEK?(O #)XXHG(2'
MO"GM^RI]M%"MS7>BAYI&Y-K^9M(Z;R^&10>_C[V$=$K:)!8DN1!48Y%@WS(<
MY%!8CG!L]OWZZ4&L"QRH_<)],QR>LW?R;1%]5-K$3;(\7C"15*-WW3Y[ZYP"
M[]D/AQDS\+9C"Q#"CEAO:;<#WCUA_^2OAQT3I!V1UC'$W7LJ@HES_+VO]T5:
M]PKEL<?6WI6^M>A$9P.R+R?"_F@K@IWGQL'-@VX]I^4O-8["A[[8!]C(1(@A
MKG$ \1WQW3?EO;)<\3U@]W+(28<D#JI80_</'4[RKK#E",?'X3([7N,A)8*]
MLV\CD^$-V-?=PL4'DDRO6ENCK'R]39BRU![J-][.O^(Y7_P-$9T*L<Z@G1L>
M_<?_]XE-G[TR8?<EP=YV!3NA;7C1.-'%@-TF?L^L XAD"@915(@%+(G=,KZ#
MQ1&C\L().=[#&=PWH>,\"S;VKQ*0#YEJP<Y>@9$RVQDHO#]:: 4;)QX$C%Q:
M,_U]!J'QE0FO%R+!WC#,@Y>6EMCY'V?[(H#![^$0Y8)/U]IC"XO\(5(J0%#@
MW7G0S7^,@.WKY5=2$.FEI:4VRQE?B7A3' Q1.^'ZZ7D^)+2^5XNTE%W<\S['
M&;>WN>^.;R6C+.8M;8R'-CB$0ZP3&4.XZ:GNNR+L<]O!=7\?@_#0%Y<6>T]&
M>0+7V+8NV+UQN2'6U_X?;OV@TO\N(0$=>)\0\B>/66U_F9K[71'%I@@@A#>I
M%.R1'![AA:6S0.=!=3VB&+0<KG(XR2%/JO:.K2'!OF6X8X3W\M)JW[&"^C7A
M[\5KA'BTS_'.#J%2-Q7=J76QN@G?#[^'Z^;^F",<#A!NSWH3%M&L0<QEO*G#
MXO4[6GKN\];R,K_.L-:'#PO/H[!GO-A;,E+2ZL,!5K%[UGCT$<W<^S:A^_Z5
MVWM>]'5$*A-B;[85P5Z](39'V;<NG[S.%R@.IQ3P3LEMWW?$*CM];*SNP> 5
MI=ZNQ%YH[),D@HB]^.O"]39@>:EWIOS S<6=ZQT0L,YBRQ$F/VW=^N_>54H%
M^PFC5GL#G@G#XDS;$(V&QT#W,M]:4F2O3\^T9]^;;_]^8+1=\(<7[-!3[T^9
M4 _&]@?VM.MN&F@?C/W*EGR[MKG?Q"9(L+==P<Z).B>1;+Y[A00R(8Y4:WYT
M0;'?P%/%RK(:&^;NC07RD%!X)XLRUW1U_.291;LEKR'5@AVP S@$Q8-(YPT*
M^72*&[L(&"K&GCL^5C>$]Y+(NB$2['5A36,.D"=XOQ-SA[Z76:>V .O:G]WS
MPC#@V:6"P//]\M(2.R/N;0H+(<3N35_$<H(3L03AQ29WE*@5\LFQ&<)AHMYX
M'+C2&T7GC,OQ'1QX5OS](<Z QLM*NZ[/G:$R;5VE']0"X/NDY@7?%FLF-0!N
M=-\S8?#[Q N3A>^+/SO%K;F]G* GMW.U>R>)-)HW)]AYW[Z8EA,,>(LIK)F*
M@?C N%M96I/0@PE"0(F*I*,&^T1][Q,'0'O'ZR$0-DH- XI\O>76(SQ('*H0
M24&]#=[KQ_&N#^^Z?\::Q3[!._K#Y[%]B?<6/E3BO7((@MAX<F&132%G/HU$
M@ 3[U@G:D>+UOF56@4_5XC"O2RAB@P,@"K:Q7EPR,<=[K&G[_&9\'C%O")F?
M&E\3IN=6^M1:YM;[[I\/=G,4H<K\0W0=.VJ-]Z2'[Y'H&T07GN97W3M!<+8$
MUGH.G)YTHI7WS+<?%']%Y%WEO@<BJ:B1D\P^W@&!!Q<-0=HA:WWGD+W)81@:
M[+W,LH3LRYL3['O$(Q@X8"-O/E5KX#CW#3;'O@ERV4G'><[M0]>X]T8'@9WJ
M'?:P%C%_3G7/D8BN.[XL],7BF'O,P8_=[V=.3LME?J[W<_7S>*<;]K5!3N23
M,D9W)-;*TS_*]FEB'>/U;7A7?!<42"0:?<#R,F\G!S,GI8(=PYAPP+.<T7"V
MVZC/&:_1X'#/YFSWC,X<Z834(Y/ML+\,LKW.?CSEGG7&-OMTLQT/OLUNO?<]
M^V;I6E\A/E%(L+==P4[1H!OC13S"!: P9/_I##\,<T)U4T5>/%>(S8/\VK!P
M8$'&V\>]$YK9DO<0A6 '(I:^=88Z%;_)U=]^R,8B9\PWBI?\V1EIKR\KL6^*
M$B<4)=CKPBL-TD'^S\U_A$W@<>%=$))^NS.*.4 J3''!U?><0?%7^J2[;S_<
M<@AO"&U_7EY:FIBHC[C1&$O5B!W:[3AT4\\W=@'S% &(T<)W22XKZ0)$O% H
MCZ@8]H"^7Q5Z;_P_W-KUZPDY=I);K[AN]HC87-_TYR,@;XFO:7S_/N\P@4;S
MY@0[WQW7M+N[-KX[O&ZI& A:0CK')[B0)^)_M5L7J>1]^:1U_IYVJ-<%H%,\
M[1%C$^_X$>]E^;QA#BW8!Q )M\YV8TZ^_=O];U(B$%48OGA<8P7!,N+%&>N^
M2X0D]F+ON87^0*(\01T]$H4$>^.@ZP?[ 1$;%$HE(B;<?<"+]H&Q**0=W9\'
MM2=HB?E;-X\0^N3S/O!5;%V@*"&%:YE;A"I3S#H68;;*KS==XG/INWGJOLO]
MG-CZD?MY3RV,>7Y+6AA-Q>$DD3ZTX]IAR,9B<QT'Q:(&;G+WR>%E81.\L"UE
M@T]+*O>"#X&^7>BPE'V9-99UN2 !^\_F!+M? P>O]/9N*M= '#+416HNQ?$T
M*^PDUG6*;8:?7V O$KG >L7A(C8M]N,UG^?Z_89]Z\'X'&4]OL?9%=W<VG?M
MU'4^"N-(O]YE>KO8%T$.S?_MW>_B=]+1Y.V,<F^/E(4VY13EL,=ND/!,3F*[
MOI.ET>!PSX;G,W2%[??L7-OWKD]L]VO>M!W/?,RZ''5GRCWKY,CO=L3M=M29
M#]F3_2=87GYI0MJY!4BPMSW![@M/N?O@G=+#-Q:FNO&]8L2QP'/ZV-*\L::
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MPG.%Q>6VODJ"70@AA!!"""&$J$\D@ET((8000@@AA!!;YO\!>*T#T=BB-B\
+    245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139630494032480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>May 12, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  08,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SALARIUS PHARMACEUTICALS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-5087339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite X<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2450 Holcombe Blvd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Houston<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">834-6992<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SLRX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001615219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>flks-20220808_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="flks-20220808.xsd" xlink:type="simple"/>
    <context id="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615219</identifier>
        </entity>
        <period>
            <startDate>2022-05-12</startDate>
            <endDate>2022-05-12</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV80L2ZyYWc6NzMwZWIwNTA2YTNmNDVlOGI1ODJhYjYxMGRmN2E1OWEvdGFibGU6N2E2NmI4ZDg5NjhiNDY1ZTg2ZDY4ZDI1NTM3MjQwNjgvdGFibGVyYW5nZTo3YTY2YjhkODk2OGI0NjVlODZkNjhkMjU1MzcyNDA2OF8xLTEtMS0xLTI1MTky_669a91eb-756e-42b3-800b-2e018306ff7c">0001615219</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV80L2ZyYWc6NzMwZWIwNTA2YTNmNDVlOGI1ODJhYjYxMGRmN2E1OWEvdGFibGU6N2E2NmI4ZDg5NjhiNDY1ZTg2ZDY4ZDI1NTM3MjQwNjgvdGFibGVyYW5nZTo3YTY2YjhkODk2OGI0NjVlODZkNjhkMjU1MzcyNDA2OF8yLTEtMS0xLTI1MTky_ea91f864-7681-47b5-a843-8c4b736b1c15">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGV4dHJlZ2lvbjo1ZTEwMzVkODM1YTY0MGFlYTY5NTQ1NzdmNDNkZmE5MF8xOTcy_66483bb2-afb2-437b-9bf7-2b5777f04628">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGV4dHJlZ2lvbjo1ZTEwMzVkODM1YTY0MGFlYTY5NTQ1NzdmNDNkZmE5MF8yMDk_569f8823-c9b8-4f14-8e98-86b4e639457b">2022-08-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGV4dHJlZ2lvbjo1ZTEwMzVkODM1YTY0MGFlYTY5NTQ1NzdmNDNkZmE5MF8xOTcz_928eb024-187f-44f1-8550-760b68dfea8c">SALARIUS PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MGI5MzA3MDk0MzI1NGIxOThmMzY3Mzc4MjM4ZTZlNDgvdGFibGVyYW5nZTowYjkzMDcwOTQzMjU0YjE5OGYzNjczNzgyMzhlNmU0OF8wLTAtMS0xLTI1MTky_235e398d-8b0e-49c9-907d-cdcb79e1ab70">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MGI5MzA3MDk0MzI1NGIxOThmMzY3Mzc4MjM4ZTZlNDgvdGFibGVyYW5nZTowYjkzMDcwOTQzMjU0YjE5OGYzNjczNzgyMzhlNmU0OF8wLTItMS0xLTI1MTky_b49d4f9e-d9b8-4223-b126-f04ad999a906">001-36812</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MGI5MzA3MDk0MzI1NGIxOThmMzY3Mzc4MjM4ZTZlNDgvdGFibGVyYW5nZTowYjkzMDcwOTQzMjU0YjE5OGYzNjczNzgyMzhlNmU0OF8wLTYtMS0xLTI1MTky_53f9939c-904c-408b-810b-7f64dfa792eb">46-5087339</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MGI5MzA3MDk0MzI1NGIxOThmMzY3Mzc4MjM4ZTZlNDgvdGFibGVyYW5nZTowYjkzMDcwOTQzMjU0YjE5OGYzNjczNzgyMzhlNmU0OF8zLTAtMS0xLTI1MTkyL3RleHRyZWdpb246ZWRmMmQ2ZjgzYzIwNDkxYjgyOTJmYmNlNTUzNzJhODVfNQ_ffbbfa1b-93b0-4f0f-bde5-5a006982e977">2450 Holcombe Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MGI5MzA3MDk0MzI1NGIxOThmMzY3Mzc4MjM4ZTZlNDgvdGFibGVyYW5nZTowYjkzMDcwOTQzMjU0YjE5OGYzNjczNzgyMzhlNmU0OF8zLTAtMS0xLTI1MTkyL3RleHRyZWdpb246ZWRmMmQ2ZjgzYzIwNDkxYjgyOTJmYmNlNTUzNzJhODVfOA_6775fa33-9fb1-496d-9a97-fb90c45103d8">Suite X</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MGI5MzA3MDk0MzI1NGIxOThmMzY3Mzc4MjM4ZTZlNDgvdGFibGVyYW5nZTowYjkzMDcwOTQzMjU0YjE5OGYzNjczNzgyMzhlNmU0OF8zLTAtMS0xLTI1MTkyL3RleHRyZWdpb246ZWRmMmQ2ZjgzYzIwNDkxYjgyOTJmYmNlNTUzNzJhODVfMTE_a951fac7-d8c5-4b76-8530-d101a9b8a04e">Houston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MGI5MzA3MDk0MzI1NGIxOThmMzY3Mzc4MjM4ZTZlNDgvdGFibGVyYW5nZTowYjkzMDcwOTQzMjU0YjE5OGYzNjczNzgyMzhlNmU0OF8zLTAtMS0xLTI1MTkyL3RleHRyZWdpb246ZWRmMmQ2ZjgzYzIwNDkxYjgyOTJmYmNlNTUzNzJhODVfMTU_98594f81-9cec-4496-aac2-cec1e3827534">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MGI5MzA3MDk0MzI1NGIxOThmMzY3Mzc4MjM4ZTZlNDgvdGFibGVyYW5nZTowYjkzMDcwOTQzMjU0YjE5OGYzNjczNzgyMzhlNmU0OF8zLTQtMS0xLTI1MTky_b6a138d2-2229-4e61-ba2b-0cbf7b93ac25">77021</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGV4dHJlZ2lvbjo1ZTEwMzVkODM1YTY0MGFlYTY5NTQ1NzdmNDNkZmE5MF8xOTY5_98e186af-471b-4c4f-816d-a08f9b7affc9">832</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGV4dHJlZ2lvbjo1ZTEwMzVkODM1YTY0MGFlYTY5NTQ1NzdmNDNkZmE5MF8xOTcw_c3953f23-68ac-4dbf-83fc-064a2e615cb9">834-6992</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MjdlOGYxMTNlMDQ4NDRjY2EyYzZlYTYzYmE3MTc3MjgvdGFibGVyYW5nZToyN2U4ZjExM2UwNDg0NGNjYTJjNmVhNjNiYTcxNzcyOF8wLTAtMS0xLTI1MTky_449f0097-7c36-4290-9a25-96778ca12b9f">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MjdlOGYxMTNlMDQ4NDRjY2EyYzZlYTYzYmE3MTc3MjgvdGFibGVyYW5nZToyN2U4ZjExM2UwNDg0NGNjYTJjNmVhNjNiYTcxNzcyOF8xLTAtMS0xLTI1MTky_28596e96-c74c-4ac6-a938-4f4973fa9138">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MjdlOGYxMTNlMDQ4NDRjY2EyYzZlYTYzYmE3MTc3MjgvdGFibGVyYW5nZToyN2U4ZjExM2UwNDg0NGNjYTJjNmVhNjNiYTcxNzcyOF8yLTAtMS0xLTI1MTky_b6e079ca-dfa6-4203-a637-942361305338">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6MjdlOGYxMTNlMDQ4NDRjY2EyYzZlYTYzYmE3MTc3MjgvdGFibGVyYW5nZToyN2U4ZjExM2UwNDg0NGNjYTJjNmVhNjNiYTcxNzcyOF8zLTAtMS0xLTI1MTky_4a0b05bf-ed32-43d1-af93-6d2c83eee00b">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6NzQ0YTdjNzJmZjIzNGFhNGIwOWI1NmRkYThjZGFiNjcvdGFibGVyYW5nZTo3NDRhN2M3MmZmMjM0YWE0YjA5YjU2ZGRhOGNkYWI2N18xLTAtMS0xLTI1MTky_d0bfdbaf-944b-4825-961f-d5ea4a7ad23f">Common Stock, par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGFibGU6NzQ0YTdjNzJmZjIzNGFhNGIwOWI1NmRkYThjZGFiNjcvdGFibGVyYW5nZTo3NDRhN2M3MmZmMjM0YWE0YjA5YjU2ZGRhOGNkYWI2N18xLTItMS0xLTI1MTky_359f5017-1794-4723-81d8-5569c86f8691">SLRX</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany
      contextRef="i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjE0Zjc2ZjA2NGQyZDQ0NWViNGE0MmM5NzM2NmJmZTExL3NlYzoxNGY3NmYwNjRkMmQ0NDVlYjRhNDJjOTczNjZiZmUxMV8xL2ZyYWc6NWUxMDM1ZDgzNWE2NDBhZWE2OTU0NTc3ZjQzZGZhOTAvdGV4dHJlZ2lvbjo1ZTEwMzVkODM1YTY0MGFlYTY5NTQ1NzdmNDNkZmE5MF8xOTcx_1593f3f0-16ac-4301-ad85-1a78ee6ca158">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.<V"3J9B+7D%=*RHC_#K3),
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MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
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MJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%
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M?^:+X3]>?P%02P$"% ,4    " #[D0Q5!T%-8H$   "Q    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( /N1#%4_=0.<
M[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( /N1#%697)PC$ 8  )PG   3              "  <P!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ ^Y$,53N@F(-*!   C!
M !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+
M 0(4 Q0    ( /N1#%6?H!OPL0(  .(,   -              "  8T,  !X
M;"]S='EL97,N>&UL4$L! A0#%     @ ^Y$,59>*NQS     $P(   L
M         ( !:0\  %]R96QS+RYR96QS4$L! A0#%     @ ^Y$,51E%%?4W
M 0  )P(   \              ( !4A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( /N1#%4D'INBK0   /@!   :              "  ;81  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( /N1#%5ED'F2&0$
M ,\#   3              "  9L2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     )  D /@(  .43      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="flks-20220808.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.flex-pharma.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="flks-20220808.htm">flks-20220808.htm</File>
    <File>a080822slrx2q22financialre.htm</File>
    <File>flks-20220808.xsd</File>
    <File>flks-20220808_lab.xml</File>
    <File>flks-20220808_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>flks-20220808_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "flks-20220808.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "flks-20220808.htm"
     ]
    },
    "labelLink": {
     "local": [
      "flks-20220808_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "flks-20220808_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "flks-20220808.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "flks",
   "nsuri": "http://www.flex-pharma.com/20220808",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "flks-20220808.htm",
      "contextRef": "i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.flex-pharma.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "flks-20220808.htm",
      "contextRef": "i137d878aa20d4d209f31fb2d99e2d6bf_D20220512-20220512",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001615219-22-000131-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001615219-22-000131-xbrl.zip
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M?-C0A=B^D&Y$O!1FG;7 Y#BU6J59MZ?-CL%:]7JET6A7VHUZBQV<\H![O-0
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MQ6[WZJ*.F&(VGV1*N2[X) TH!^',KZ<L/>T?I>5[^D[3A$[G>*,3/3?GIPI
MM<!STB[E7-<LB02_@R?[0XWZH4WGJ4ZH3KMR^@11<2Y'7<"$#QN=3TR2;!#I
M*S?PHBUPKP=T9H"/W!H%PBBDEI0REP/L,=1*7>EM/_=9T<D@[,:CVE;5[[N4
M5!*J[@1#N3(&0D(KNIZ$)$M\EPA4Z:J3#/G"@_Q@15\,U0FP ?>V,$^,%S.
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M>,7&O3W_*G4[WL">0_^#QMP^^-BW#QJ7K9,&L8?M\VZG/^A!67O@KIPS#HY
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M4'3=\1DAIT;A91KH#TFY7S-+\M:FZ 6D6Y2<R)O!1S\=AOO_#U!+ P04
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MVX);DW> C)9L71Z/VX7U)JP5=L5LERW9W[;M][.-#(+MJL]Z?P!02P,$%
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M7\EQ-5]*.(_B#5!2BD]&;TU$2)?N$2>'JL8-$Z&S*8?<$$M,4R=TSA\5URG
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MOC8,TI?3;KN+R!DB)<&_M!._E,UOA3D6%%<L@H5FI@8]:)!C'P6<G1+I]\B
MJ=+2(K=9V1#JW/,0+7G4%UJ7M(W$R?+G$H95'OZ&=HWG,%=(=TMX[_(2A>W0
M*YSW=5PXT\ (X<?P8O 0&>">=B7M,D%XQ,NFK  EW6CX6Y.VZ*PE]0<-2U?[
M+03-T$ZEB4:#S>[26LDF].FK138;_D)F+<\A':7M$Z)6VS"J:4\4L['<WI:"
M@K/;SCJ6BGA@FO(#5H-8[]D#':R6^J3IMC4T\" 4B&6+M[@OI7S)UD"@^*2R
M3SS1P57CV2^:URPU"GA3E("XQ0A!LW3K?%ZNLW+V+\:Q/S!3XE<)$W>!J<(W
M^]<ER:V?JKSCZISJBL%2PXLP 'Y##Y^U3)3L.6<>GCW.-Z$MH)>)CIZXO_MS
ME74Z<5,2B\:9$NM.$#,='O+A.[8*%)DU/[ ^\!2>X.5PDL$6LM%2P.+$#'F+
MU\/MXL51.[?70;SV6W+W!^HGGX>(FE;K H5M48>STZ$=-DV"*9!BBQXML+5;
M^!8/M_ MA!1B^1N(+H EC@3$G"8$,.H'+.'UG?/V&K\#2MV2RXZT4O.B_;<?
M*N#TDA$^TE$%+#49/OA'-Z>\V5U?'G\H" 5M_03]0:X'[QE?Z&\#ZYMZKIQ\
MK/R;4VCSCU?]D-IWMU19O[^K@4$WW/F9J!S/=/E8&4BCWPJGB(]D+&^L#(;7
MO<$[ECIX"%V/$([T[/7V.@FW?2Z)?)6E#U\PY<=W=5/28'0@G&T[K<YTK$JD
M]5-JJYG!S],'_6A0&JQ&J<L>D214+Q3'>L-]K-Y@W&I";.[]/\EKURY:8[B/
MAXLA.:2Y("5K,J!VN(=[]S0TZ;EH9/LCCUMR%"+W>6H&(>I@*0&"#F7&M'G\
MUEL=[F=)%13%7Z##X:PAJ7NSLKMWZT^<5VVU85FL8>X"]F7*U:?+2[M K#8:
M%+>,/![D,Q;7;J:9<]JNXR9@Q_UNT":2 0W)_-;#N\7HIU?IN>%STC.FJ-.W
M':(1_)CZL*M?7C1E\P8HYH39_:*9JM5]8VL8V*>KN:D)M[C?8TJMJ]&EXK7I
M/QI5I?1W.(8,6)F"LB,V@2OPBPLE,H 5I$8(P M7D89)*H(<R/W= ^FARF"(
M:Y),&C@;$/&3G_ -X4,P0.U=[SQWF$UMKK#=XI2YX_ZC+?_Y0[IF-=@S4#*L
MX;1/ (C.Z8_TZ<G56!\M3%5EO&/#(:=S3?A/YU9S$NM>XNJ@S(]*1[T]#?;6
M0/D>\Q(3C?V-4 JJSY(!F47CP%T^RLW7G9-9Q"WH<IX[23;3B)*VO38H@8WT
M//1'G!9O(BQ*Z G CWA1+)ADV)1,!NS*!%(2FQWB(70YDPPX-(V@=/',!GIL
M&4&+3:1KQ#>C7Q29UXK5!?&8.J\W1!931NO EZV8TF\6R(\H# 7UZTY4^]QL
M;3+6"HQQ2[YIT?#AM;YZ70%X4^YV\U.[Q(ZE+[V:Q?86QTX(&>CR5UC#U2HX
M?O9T)2X.7EPS(E]55J'0R@$>C*+F_I"V_%!O</YD4_(XO)ND@EE*NG=/ZAAX
MS2/L#VY9?G3K-/WO*/4GSBO]/)T[6Z $4'U6RF+>Q4/"/TT=HM4Y]LUW[<MH
MFZ1)*CHAM@I7AJ\MZ%1:Q;E)>&F*3I1@PI=]DB$J(5'&?)TMIG/?WM#D7/^%
MNBTU_OG>QIN"[K+>2 X*35]"%:57:#2M_/AP8B%?(I1A[4RQM1W?1+&U*4E-
MO,J3L\6DIFQ>.]!=:CQ^:LW2\$.WH-(E/ZX.=")1$!Q?&/][[&O?9=3::^Z3
MH:!UGFQQ%L?QJ-KC^=^I@OGZ_G+8073.+A -?:U!G=F;2ZHH=-S:\N<H2^Q=
ME?5^]X[ESV?GQ+,UZ)3XQ2!AYUB.Q&!]H1/BW.-T?9S$'Q)LT3CE,W3HM"UG
M^TLD=<:9SB6\GS;!^^%6*OAH*"2 0D2@*KC:\X:*QY:25:!5/ZMD9]6'Q N,
M$B%!0XBR!2(1I"0[0A]%1Q1!!SI?+.$ 262 GA&H1.,R&9 N3E$=.)8F,F#4
M"$0AZY@G:6</I/A(/UFAFUO@-;^TT^%,=7YK3"J(1(\@ \1MOY(!T[(79(!.
M(C$"_@N(%R,#"/G>E!Z?#AX0.25/#@N"2<?M7-O<IBN$KN:T1*%#XW]/H9\F
M(8AL)^-(&:PVR0">!-UE#:;L5J<V"2BOJF@=\%(5)>H7I4_U#N$4W8T7[R?D
M0J,1BRUDP-A'26S7$DF=0N0"H!)$BBR,BH .E."5B#MPXIV,CB4U,B (A"+R
MK#ZE:(/#!Y2O);@(>9%-Q#@OZ#&/Y&&3X=.6QH(_KV@G1&!X7N1.#H$=W-6D
M(4;,.?E8E1/NH90]FU3*H\J1J+2& ,9 -)O^E- )O@TJ'[ +L0]%C-@@4 ZD
MMP%GG& ^=^UF7H6G>J\>5G <YNSF77B$B/<O70WP$NJ9/4F+B[#]-B=:_$?E
M_2!-,!6[Q"!?#8,FP,7]QGIK6O)2HW4W\"V$I[4=Q.:Q>'.2T'@AEE7L4-R3
M:9#V7D9+ZUY81HA@ _:PRSK%VBAK_H1#_\&1 Z&'6%==V$8L)=U2>\1C;78X
M(+1H,ZE/Z(1_02QG(@[5(S0IW@V$DU+"\)F]@B(=V+B$!J]P"ZC2XXG]HM8?
MWKT+2?SA_B O"B\7AZZ&X:,I;M@!$7E/<#\VP]4Z'D>R@=)71R,FQX&&%5T=
M&I"^)1;@"_HYL\DJL;$(G:874P%=PA]_;HK0<+QC\85I28Z3;D488):Z8(P+
M(7&]*I6\)CG>RAEN9_FMMZ2MG*>O@E<6Q$D,^<S]O5U-) &P:=Q5M;?INCOX
M.36'^W^O]-OTWP@63SQC$F!Z,E<19VJ"*(%]V;;,5]@?+AL*J2/1ZZ'"]=+;
M%- I<F;Q?C7;5L/>&W.W;=S:C/JAWV%]:8#9H6!@#+3Q+HHVUXMWQ5O?;#*1
M26D+5"U(BR]>$4IH<;"+BR'HE.Q8C=T[.+:=S(<NFK:53+^Q(CQ#+UVE4,SU
MR0B]*ML74]?*W'(/71_Z3E,/"CW+=#P^>NDB.J 0/#M+NLS6-9;1,D*@RY"M
M_+5M^7XE*_:*<(U "J2(LH0*$#5/!"N!OC($"&K)( ,>8V;B9Q<>!>OCX._*
M^YMUS>4V=2#^$:Y8JX_HM"0-:>S5%+J9^BHCBX+U*?56T^P_^B)!XM7J.WLL
M__Z$B3D UA,B4;HI.::'5<?XU=W#2W]_ABU3!$9'Q>*0,.\'<>4*!??-OVJJ
MOA4ND*11'0X,7?W_](_QGP1'?&]AA/"(\<)14HK64YUO,#[(H=N)1J)JTTDY
MD$]#R0-Z)<!XN/'(X8<%SEA-29S8=*QY?LR!D4YJ<ZP(03LU3Y[D-;9U?%JM
M"S";>1)D-FT]O1K*5'>Y CE&68.!=K561.O@T;V[:(90>:?K5R8J$"V"/L.U
M9QU_I3G A_BF7I7J=G\OL%=HF?'&7ZF;K&4OG[Y2^40UL'JB\%&'XX+I)J_O
MXZA:>Z$_)Q5/>IYDV=6NOV_PVI^VYL!:]#&NY-/NK41X<B4Z)U/_EL8"CSE&
M0W)Z.$E<H^X3U='<S[M>%QXH7U04S)S"<]MT4(R(ZY[CVUPI'UW4;F\FS>A]
MAP/Y$I\4#@@ED.@67A5HWAV^5F.)W*?@!$9\;ARQ,'%12*(?OK :+/%47*(G
M6(:,V<ZSR3,VYXG=4<DS-\44&(;QIZ(0>A5GN_6M,-/6J/TI]Z:6IG37V!=_
M>01,+-^<T# 0VX@YD/OP?NDHB"!6+1DQ:RPTTT #6FE.6\O<*N .OP__=?2)
MMUC4B5$/ 2=</_=AM!SPTXBK0 X"&TIV50M)(U=)PB/>MS!D0,J8>M6K 5):
M!&#%C?I=]V??X6KPMJ?DST*[;X*>Q4IN0;]9<^O3N@X2ENK@/=#H4[]>%)0!
M-/LP[M+YHIQZQ45E63J>7\CSR%9 6-7E)DOA*Z@=*?:C=ID5U?OD:WJ7F[VT
M5_2B CV2FQ:OCDB+JKO\&+\1!$RP.[<+/6HZN G/?" :3;*"7-%2PS$R?+2O
M[6$4&FM?6D;LVF.!:)VUUKG-S)!P;3_&'=X>+Z9GD68L0S?/F<(3B:]'.P1"
M++KKZ.MA3"]F70K310M@['>!'&:.',8O<>96Q8QAVP^6D;/N.:1A1-U2+-0=
M1%L=\UG8U%>&;<G3XLV&XV"R]\L ZMI4 /R?*?D\XW"#MG&?%?L\R5].]"N^
M[S9_QM)A%/P2SSY.Y!LH#RS4M>OHV+Z$/""-"]50$CLM^!09YI8?",>+KKHW
M3%0)RRJTN6#YMY7-VY4"@$Z2&R_V<_N>;LG-_@$F./0MC2"/I1S^?J&HW=R&
M;M/(%0$&7)"R[+S']U\]1,/UCNS4T-O]V97W+CY=[_QVP.6,*=0>(>AAK]LT
MC<M7J)OVA"6OWK7"5&;60=58_,=:EU)!=6D)$"HRH$O2"T6UX3D[F;1D#'X1
MJU/?O<?*Q2_GG)FJ+@=JF)6.#8 R]XQN\1JGYO %&DFZO!4J?2QIF.!>NV%R
M_S0<1 +<Y6V$6V#) !+]ED@+:,]R!:9!_\5@#WZ36>11H=CE&RYIGL0W1<5P
M/H&D\S4=B^Q9^^9)75AMFM0^Q *R!*HE ^(C.+#:MMC%E.)Y3XWK2%>ES"$P
M3^:N-3.IQH4ZRPIXW_L3NB'BM?.]N4<O[2]:3<#G7*Y,1:SO0FY,W<  8Z=6
MYUE8MIZCE8\Z>@4)YQO>X*GN#?-B8ZTB:>\FY9*WYEGC-1AQ EN<3GO-5,>-
M1>.2>7N[(:\7Z<-WF1*$Z3)OR/"GY^Y ?4RG$5;XM(JF'E.J6<8%\(#-B?'-
M^X)KCY^Y)M6\>B Y3Y4*WH^Q3-$JC['D!C!1F< U;%-,J]2><.1M>I?JS5PH
M0C54.M*A*Q=;+T_L^?)E#SGG1)1\Y4V25:_]O.9QW1K1$F\O2ES%'E\K^MM]
M>!D!41B^LNDDSJ"0?]UD,BJ9I<E.3Q%X\-FS(!,SUZ7"W#7\+<1>9[S$(BM[
MW"163$BKG#D<.#?:6']R0@:\]B,:'Z?C-XI) P7*F<O(!(C(]GG +&=2\<],
MN[D%K:YU8J[.H\I(2\#+??7P,&2*@7-035UDZLX;V D+B8/(8&YU;=@-/LQ(
MV#MGQX +E6$Q2' D9K@KF,%/=,Q+Z"@&?&1/8D@ JRW57TX>M1^2H*3@'B4]
MOOMD@*/T9_@D@R$6\P%1CL3--RUIEQ<#/:[:P]*!&!-5HWBH9Q5'46.N/.E/
MQUF!F!FI,O@6PG'KSHO^YZ1FZUF_.:-@!GGB^U"?5]7NJ%=2&&3OZTNF..-%
M@-!Q[\ZWKS^>G]FY#3^!JEN=1R[-4,B3=@L%[6R )6.(YXAEF&\;L#8M.N.?
M%],*4Y8394);LD$*QY92X3:[XSOUDQI&X,B#<_[WKTB_'9#-VDXCNQ'&7Y:V
M>/-;%CQ.1]0;>J1'T8$2W8<*^+V+1Y!^C?MX.A3C7)*CQHX#QOZ7T[AU0_+
MVDTUD66_9!47C&]_,>2/N6RL^95?:M? .;2I95&9OI/JHU5V,N4-\Z10EQ>G
M+S-? !>\$5EAUIW0F:6^)0&%30JO9=RLXS-?=O"LZW.N;W3:W=<3%^J2-89,
M.! D,)9[R%EO-:'/P[Z?SL8\WLEM($7]'07R\SM@+[-QW_6\?+B[=!AH= 1?
M7Z4-MY1;1WN^JCMR%WD5=O&' "060EAU,#XH''R9*+>7&U.=QU&;5Y*0D*T;
MPS/WYC6CS,]=R6T6O"ASVPA^ T653?^<SJ2A,T/1@71"U(%DC#I8UGE8=[>P
MQ59)^9 !@*D'KO1'WT(/^DW?D 3QQ&4^.%-(K*+-]%EC4SK5^NPCJKE;D(C4
MMVR2A_YH]UTP5GJYX,LKI-W=<]S;MQ\:JL3$<F_E)R=JO!BNUE6GA\]Z2N;0
M?9CLO*B94D^1&$EQ=-HXFLAAVZKS-G"M>\^_9EOXDO1^RZ=:P0,:[JM^#-O3
M'X/M@-K/$=V@*_@H9\6R%2\N\ZS41SEA ;(U!%MCL33*=A04_&%[C&#8S'VY
M\RM[^-\P2"Q5V",#?+20N+!S,N"GLL8W,N #(1'/=<$>H8^?@WI)XYZ0>##H
M^[([O$6Z]RT063S=^I' N$6$+>D:07P$PA#":(R!Q3V5L;&MMM-;-UA5:TL-
MKQ/"5/]-Q-1\C'%PRQB3_#)C^-;#ZX>9#L>Z )4.^^/_X>KD@VU"*^9CHKMA
M+]Y)3=7X,<S8;.3X'#1]O4IJERS!GJ;4'\05<'0@ Y5ZVVM==%F&)&$M2?O&
M$%_\1;]=28\/NQ,XM[)U(_][>O1A-_=%:<=KEN%,D/T[EZ59R\@JT$H_5&F.
M,/PWI#MA2D_S<3=B:<B#.$D8/J9 @CE6*:%!FAN<8]<!#SC-.95J7G4^NRWP
M>I/6U7P45*<K\_;)\\IT0KMYT?;01.G^8E5'I6'!U&\4)IWF^B,NOK8/@WO#
M8ZT^;Z%T@8BD7.1,_;'B><!=C<E2?41K?!C+@<RNY $L#L%\#(PM$$HR&-VS
M%!:2K_MQV7:I57D?JCG;X:XX7.J:-E,\K(&<FR3%+;[:H$/5K>X87ZB _DSN
M$[)SCMP'G;CQ,1BD)CXX<(5Q."YWL>Y9J5Z3&7CP'^> Z>U0M%!W*LP)C((G
M"-7UW,=GD ZZC,-=5_PB?CDC;[EFSPN6_OU<0363RE(%&0F]0^PEE#<6%]GL
M\$;VIIP4*04%L]9;:,H_R_A'F%9?79,#(W_T^UJ91$=GD]2!(@5(3GE#.5VU
MDE^8]>G*)-8:OJ=$ZD!:YS!G!+ 9D__>6FZ;4PDL4F!CY*%T_\%?WZW>R 6*
ME,['/JG=) $Q\QDRB8Q)X7@+M3N!+N](JA:'\"O$1H2+!\*=#&"[AUC!%\%^
MYA;U/E.K&5]7.V."MH1.FWY323RAL.8=(;QQ!$0U,FJ>#%C5=LIVMDN5I):H
MS\Z%O#CQ.W^0K):E9FP2NE/5#&4V'4N44$UZV]"4[7%U&FV^&PG@45BE\+Y)
M$+.>T!Q%;+X>@V(5L.RO&K!*N/M^32XSVZ@Z)L'+@QQ6]SOFAR2)&]5F3I;.
M%X\C%#M^V,3%H]\V84T9OY)<K+]MG<=45[AS+&3U6 ?5IHP.,<;J"GY.E'P&
M7MG;*_NQU/(BQ*&;/@4QZ=D71+*"K=I\35Q3$\=J=W<H3C48B^NW*RG-.G.T
M)/<-?H^5G$@-I2MVY?7_Y'J[MT& T&Z2F+5E_LGCKX&AO=A)T-[\]N;79I@
M07<$PKN%.UV\T:88-#ZXVM>E&-%(WP<X9B\;S[>];6'M\U7 <^+[\8+=F%GB
M0CO;6;X"!T?51'#C]WFMN:\?.?]Y&6@NR[)F/N%5J&"L$,!NY9Z@IE>"U]-N
MFSRQ[6V(^1J:\5OS 4^_YL1J8N$R5/ %@C4 M.=X>6<OR,GY'YLO6MS.-Z)_
M;4OJZ!9^VR[M>+('R=GSIXO_6G%7-7?#$]?1>.#=KZW#;J7WT,S)./3"/$)E
M_$"\$6:;[A:EFX+<K>6__T"XI+2HD5BNP3O_IX8".V?VJ4H&/K=*S_,;ML@
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MTW#ZXJS3K.VG^7=E:+)B;9)G6>=V9!-L+60,S K)9;_VV!0:DR&AF"J4R,"
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M^>\GV_D6?/CLM^85!U#G^D[U^P48%2":P"59Q),@%8>))=&5J2.]LF:UAH9
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MQM1GYL"\($$&JAF#+2IT6EO)0&Z[^W$ *IZ4MC:ZM6,"; ^R'EIS3PX?J7>
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M<RTR,#(R,#@P.%]L86(N>&UL4$L! A0#%     @ ^Y$,55E8,J*G!@  63$
M !4              ( !<9P  &9L:W,M,C R,C X,#A?<')E+GAM;%!+!08
1    !@ & )(!  !+HP     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
